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ABSTRACT 
Regulation of Retroviral Silencing in Different Cell Types 
Cheng Wang 
 
          The replication of Moloney Murine Leukemia Virus (MoMLV or MLV) is restricted 
in mouse embryonic stem (ES) and embryonic carcinoma (EC) cells, but not in 
differentiated cells. The restriction is mediated by the primer binding site (PBS) of 
proviral DNA of MLV. A restriction complex can bind to the PBS of MLV and block the 
transcription of viral genes. Two major components of the PBS-mediated silencing 
complex were identified in our lab, ZFP809 and Trim28. ZFP809 contains two conserved 
domains, a zinc finger domain responsible for DNA binding and a KRAB box recruiting 
Trim28, and hence other transcription repressors, such as HP1γ and ESET. A protein 
called L1td1 was identified during the purification of PBS-mediated restriction complex. 
L1td1 is a stem cell specific protein but little is known about the function of L1td1.  
          In differentiated cells, the replication of MLV is not restricted. Overexpression of 
ZFP809 in differentiated cells is sufficient to re-establish the PBS mediated restriction. 
However, data from various expression libraries shows that the mRNA levels of ZFP809 
in stem cells and differentiated cells are approximately the same, which indicating that 
there is some post-transcriptional mechanism negatively regulating the protein levels of 
ZFP809 in differentiated cells. To study the post-translational regulation of ZFP809 may 
help us understand how retroviral restriction is regulated in different cell types. Here we 
found that the down-regulation of ZFP809 proteins is due to the rapid degradation of 
protein but not on mRNA. The protein of ZFP809 is degraded rapidly in differentiated 
cells but not in stem cells. The last 50 amino acids, as well as the lysine residue within the 
peptide, are important for the turnover of ZFP809 protein in differentiated cells. The drug 
MG132 can stabilize the ZFP809 protein in differentiated and in vivo ubiquitination assay 
show that ZFP809 is heavily ubiquinated in differentiated cells, suggesting that ZFP809 is 
degraded through the ubiquitin-dependent proteasomal pathway. Interestingly, the protein 
Trim28, which is an essential factor for in the silencing complex, can promote the 
degradation of ZFP809. Mutations with the lysine residue mutated to alanine or abolished 
the interaction between Trim28 are less ubiquitinated. A small drug, MLN4924, which is 
the neddylation inhibitor, stabilizes ZFP809 in differentiated cells. Overall, these 
observations suggest that, during the differentiation of mouse stem cells, ZFP809 protein 
is eliminated by the proteasomal system, which leads to the loss of restriction of MLV in 
differentiated cells.  
          In addition, we studied the role of L1td1 in retroviral silencing. Knockdown or 
knockout of L1td1 partially relieves the restriction of MLV replication. 
Immunoprecipitation and pulldown assays show that L1td1 might interact with Trim28 
and ZFP809 bridging by Trim28. In summary, L1td1 might interact with the essential 
factors of silencing complex and help the silencing of MLV in stem cells.  
            Proteins of the nucleosome remodeling deacetylase (NuRD) complex were also 
identified during purification of the restriction. The NuRD complex is shown to be 
involved in the transcriptional repression. However, depletion of single subunits of the 
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The aim of the work described in this thesis is to increase our knowledge of the replication 
of a prototypical retroviruses, Moloney Murine Leukemia Virus (MLV) and its regulation 
in different types of cells.  
1.1.Retroviruses 
          Retroviruses are a large family of enveloped, single-stranded and positive-sense 
animal viruses that contain a genome of diploid RNA. The hallmark of these viruses, 
which distinguishes retroviruses from other RNA viruses (e.g. polio viruses and influenza 
viruses) is the reverse transcription of single-stranded RNA to double-stranded DNA and 
integration of the viral DNA. Upon entry into the host cells, the single-stranded RNA 
genome is reverse transcribed into a double-stranded DNA copy, which will be transported 
into the nuclei and integrated into the chromosome of host cells. The integrated viral DNA, 
the provirus, thus becomes a permanent genetic element of newly infected cells and serves 
as template to make new viral RNAs and proteins to assemble new viral particles.  
          Many retrovirus-related pathogenesis have been documented. Some retroviruses that 
do not carry a transforming gene, are still able to induce leukemia or lymphoma after a 
long term of latency (Anson, 2004). For example, MLV causes T-cell leukemia in infected 
mice by insertion of viral DNA in the vicinity of a cellular oncogene, where the strong 
enhancer function of viral promoter drives the abnormal expression of the oncogene (Lazo 
et al., 1990). 
          Rapid tumor formation and mortality can be initiated by acute transforming 
retroviruses (Shackleford and Varmus, 1988). The genome of some retroviruses, like Rous 
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Sarcoma Virus, have acquired a transforming version of a cellular gene variant, v-src, 
which is delivered to newly infected cells to initiate tumor formation (Rosenberg and 
Jolicoeur, 1997). The human T-cell leukemia virus, HTLV, is also able to induce T-cell 
leukemia in infected people after a long period of latency. However, the tumor 
development of HTLV infected persons does not result from transduction or activation of 
oncogenes. The mechanism of transformation by HTLV-1 remains unknown (Matsuoka, 
2003).  
          The most notable human retrovirus is human immunodeficiency virus type 1 (HIV-
1), which is the agent responsible for the development of acquired immunodeficiency 
syndrome (AIDS). Infection by HIV-1 promotes eventual loss of CD-4 positive immune 
cells, then immunodeficiency, culminating in severe opportunistic infections (Stevenson, 
2003). According to the report by the Joint United Nations program on HIV/AIDS 2013, 
there were 35.3 million people living with HIV and 2.3 million of deaths caused by AIDS 
in 2012.  
          Although most of the integration of retrovirus causes genetic mutations in the host 
genome, not all infections lead to disease per se. The host development and survival are 
not affected by infection with some retroviruses, such as spumaviruses (Meiering and 
Linial, 2001).  
1.2.Moloney Murine Leukemia Virus 
          Moloney Murine Leukemia Virus was discovered as an agent that induces T-cell 
leukemia in mice in the 1960’s (Moloney, 1960). Since MLV has many experimental 
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advantages, it has served as workhorse for studies of retroviral replication. Wild-type 
MLV is not cytopathic, allowing study of long term virus-host interactions. Since high 
titers of viral particles can be generated in many rodent cells, many stages of viral 
replication can be easily monitored. Monoclonal and polyclonal antibodies against viral 
proteins are available in academic labs or commercially, and there are many sensitive and 
rapid tests to probe for the presence of replication-competent viruses. The basic 
mechanisms are representative of many other known retroviruses, and as a result, many 
findings are relative to other pathogens like HIV-1.     
1.3.MLV genome organization and virion structure 
          The retroviral genome is composed of two identical single-stranded RNAs. The 
genome of MLV is 8.2 kilobases. Its organization is depicted in figure 1 (Petropoulos, 
1997). The 5’ end of the genomic RNA starts with the repeat region (R) and the unique 5’ 
region (U5). Adjacent to the U5 is the primer binding site (PBS), which serves as the 
binding site for a specific tRNA, which acts as a primer for the initiation of reverse 
transcription.  Following the PBS is the packaging signal psi, ψ, which mediates 
encapsidation of the viral genome into the virus particle. The two open reading frames 
contain three genes, gag, pol and env. The viral structural protein-coding genes gag and 
pol lie in the same open reading frame and are separated by a stop codon. The env gene, 
which encodes the envelop glycoprotein, is positioned downstream of gag-pol and with 
some overlap with pol gene. Splice donor and acceptor sites (SD and SA respectively) are 
utilized for RNA splicing to generate env RNA. The polypurine tract (PPT) near the 3’ 
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LTR is a primer for the start of plus-strand DNA synthesis during reverse transcription. 
The 3’ region of viral RNA contains U3 and R. The viral RNAs contain poly(A) at the 3’ 
end.  
           The RNA genome of retrovirus is converted by reverse transcription into the 
proviral DNA, which will be integrated into the host genome. The proviral DNA contains 
a complete LTR, consisting of U3, R and U5 regions, at both ends. The U3 region at the 5’ 
end, which contains the promoter and enhancer responsible for the initiation of 
transcription of viral genome, is copied from the 3’ end of retroviral RNA during the 
reverse transcription process. The transcribed RNA is capped at its 5’ end with 
m7G5'ppp5'Gmp (7-methylguanosine). The viral genes gag and pol are expressed from the 
unspliced RNA. While gag protein is synthesized directly, the expression of pol protein is 
regulated by a pseudoknot RNA structure which recodes the stop codon and extends the 
translation (Felsenstein and Goff, 1988; Houck-Loomis et al., 2011). The pol gene is only 
expressed at a low level (2%-10%) compared to the gag gene, and is only expressed in the 
form of a Gag-Pol fusion protein. The env gene is expressed from a separate, spliced RNA. 
  
After the assembly and release from the host cells, the viral particles are cleaved 
into the mature form by the viral protease. The maturation process includes the 
condensation of the proteolytic proteins in the viral core (Figure 2), as observed by 
electron microscopy(Nisole and Saib, 2004). During the maturation process, the MLV Gag 
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protein is cleaved into several proteins: matrix (MA), p12, capsid (CA) and nucleocapsid 
(NC). Each of them plays an important role in the retroviral replication cycle.  
         The products of the gag gene are involved in viral assembly and also in the early 
phase of viral infection. The pol gene encodes three enzymes, protease (PR), reverse 
transcriptase (RT) and integrase (IN), which are all essential for the replication of virus. 
The transmembrane (TM) and surface (SU) proteins are encoded by the env gene, and are 
responsible for the recognition of host cells and viral entry (Figure 3) (Coffin et al., 1997).   
         The matrix (MA) protein, located in the interior face of the lipid bilayer of the virion, 
contains a myristoylation site and a hydrophobic region which are critical for membrane 
association (Granowitz and Goff, 1994; Rein et al., 1986). Some regions of MA are also 
required for virion budding and envelope capture (Goff, 2007; Jorgensen et al., 1992). 
          The MLV p12 protein is a structural protein of the virion. Some mutations of p12 
hamper virion release, indicating that the p12 domain acts in the late stages in the context 
of the Gag precursor (Sabo et al., 2008; Yuan et al., 1999). Additional mutations in this 
protein specifically affect the early stage of MLV replication (Crawford and Goff, 1984; 
Yueh and Goff, 2003). Recently studies show that p12 is part of the preintegration 
complex (PIC), and affect the transport of the PIC to nuclei and the integration of viral 
DNA (Prizan-Ravid et al., 2010). However the exact function of p12 protein is still unclear.  
          The capsid (CA) protein is closely packed to form the virion core. Consequently, 
many mutations in the protein block the formation of the retroviral virion (Schwartzberg et 
al., 1984). Many gag mutations in CA also affect the early stages of viral infection (Alin 
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and Goff, 1996; Auerbach et al., 2003).  The only highly conserved domain among gag 
proteins resides in the CA domain, and is termed the Major Homology Region (MHR) 
(Craven et al., 1995). CA is recognized by several host restriction factors (Wolf and Goff, 
2008), such as Trim5 alpha (Perron et al., 2004) and Fv1 (Pincus et al., 1971), and hence 
determines the tropism of retroviruses.  
          The nucleocapsid (NC) protein is a short, basic protein that coats the viral RNA in 
the mature virion. NC interacts with the ψ domain of genomic RNA through a zinc 
binding Cys-His box and packages the viral RNA into the virion. Thus, mutations in NC 
domain impair the encapsulation of viral RNA and can dramatically decrease the 
production of viral particles (Meric and Goff, 1989; Rein et al., 1994). Some other 
changes in the NC domain, specifically in the Cys-His box, have been shown to affect the 
reverse transcription of genomic RNA (Gonsky et al., 2001). 
          The Pol portion of the Gag-Pol polyprotein is processed into three enzymes: 
protease, reverse transcriptase and integrase. After assembly, the viral particles undergo a 
maturation process mediated by PR to form infectious viruses (Vogt, 1996). There are 
morphological and biochemical changes occurring during the process (Figure 2). PR is an 
aspartyl protease (Toh et al., 1985) and is responsible for processing and maturation of all 
viral proteins except the envelope glycoprotein (Crawford and Goff, 1985).  The envelope 
glycoprotein is processed into SU and TM proteins by cellular proteinases. PR may also 
participate in cleavage of cellular protein during viral infection (Shoeman et al., 1993).  
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          The reverse transcriptase (RT) is responsible for reverse transcribing the genomic 
RNA into viral DNA. It is the hallmark of retroviruses. RT mediates the complex process 
of reverse transcription that results in the conversion of single-stranded RNA to double-
stranded DNA through two enzyme activities: a DNA polymerase active on RNA and 
DNA template and an RNase H able to digest RNA in the form of an  RNA-DNA hybrid 
(Tanese and Goff, 1988; Telesnitsky and Goff, 1997). RT also has been shown to interact 
with eukaryotic release factors to modulate the expression of Gag-Pol protein (Orlova et 
al., 2003). 
          The integrase (IN) catalyzes the insertion of double-stranded proviral DNA into the 
host genome. Generally, the integration is not sequence specific, but MLV integration 
shows a bias in favor of transcriptional start regions (Mitchell et al., 2004).  
       The env gene encodes two proteins SU and TM, which stay on the surface of virion 
and serve the critical function of binding to host cell and mediate the fusion of virion and 
cell membrane. The SU serves to bind to the target molecules of host cell and TM serves 
both to anchor the virion to host cell surface and mediate the fusion during entry. SU and 
TM are synthesized together, then modified and folded in the ER and cleaved in Golgi. 
MLV SU but not TM is glycosylated.  
         A structural representation of a retroviral virion is shown in Figure 2 panel B.           
1.4.Retroviral Replication Cycle 
        The retroviral life cycle can be divided into two phases: the early phase (steps 1-5, 
figure 3) and the late phase (steps 6-16, figure 3) (Flint, 2000). The early stage of 
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retroviral replication cycle occurs between entry and integration. The late stage starts from 
transcription of proviral DNA to maturation of virion. 
1.4.1. Early events 
         The infection process begins with a receptor-dependent attachment of the virus to the 
surface of targeted cell (Pizzato et al., 1999; Sharma et al., 2000). The interaction between 
glycoprotein of viruses and the cell surface receptor facilitates the fusion of retroviruses 
and host cells. The uptake of MLV is mediated by the murine cationic amino-acid 
transporter (mCAT) (Wang et al., 1991). A human homolog of mCAT is different 
significantly from mouse mCAT, which explains the inability of MLV to infect human 
cells (Albritton et al., 1993; Yoshimoto et al., 1993). Amphotropic MLV uses a different 
receptor, PiT-2, to infect both rodent and non-rodent cells (Miller and Miller, 1994; van 
Zeijl et al., 1994). In the case of HIV-1, the receptor is CD4 (Berger et al., 1999), but the 
fusion process needs other co-receptors, such as CXCR4 and CCR5 (Bobardt et al., 2003).  
         Binding of the envelope glycoprotein of MLV to the receptor and fusion of the viral 
and host membranes results in the delivery of the viral core into the cell (Albritton et al., 
1993; Kizhatil and Albritton, 1997). The interaction between SU and host receptor triggers 
the conformational changes of TM, leading to the insertion of TM molecule into cell 
membrane. Lipid rafts have been shown to create an optimal environment for fusion 
reaction (Lu and Silver, 2000). In some cases, binding of the receptor can trigger 
internalization of the viral particles before membrane fusion (Katen et al., 2001).  
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          Following fusion, the viral core is disassembled in a process called uncoating. It is 
the least well understood process of infection. Mutations in Gag proteins, such as MA, CA 
and NC can block the infection before reverse transcription (Alin and Goff, 1996; 
Crawford and Goff, 1984; Reicin et al., 1995). The cytoskeleton network has also shown 
to be important for the entry and uncoating of viral core (Kizhatil and Albritton, 1997). 
          Reverse transcription is initiated in the cytoplasm (Zhang et al., 2000). The viral 
reverse transcriptase converts the single-stranded RNA genome to double-stranded DNA. 
The reverse transcription begins with elongation of a cellular proline tRNA serving as a 
primer(Palmer et al., 2007), and is finished by a series of transcription and RNA/DNA 
hybridization and degradation processes (Figure 4(Flint, 2000)) . Two template transfers 
of short DNA intermediates are required for the complete synthesis of double-stranded 
DNA (Telesnitsky and Goff, 1997) . The viral DNA is associated with viral proteins and 
other cellular factors to form the pre-integration complex (PIC)(Fassati and Goff, 1999; 
Risco et al., 1995). 
          The exact components of PIC are unclear. For MLV, viral proteins, CA, RT, IN and 
p12 have been reported to be contained in the PIC (Bowerman et al., 1989; Elis et al., 
2012; Fassati and Goff, 1999; Prizan-Ravid et al., 2010). The manner in which PIC travels 
to the nucleus is also not entirely characterized. MLV PIC has been shown to associate 
with the microtubule network which indicates that PIC might be transported along the 
microtubules in cytoplasm (McDonald et al., 2002). The nuclear entry of MLV needs the 
nuclear membrane to be broken down (Lewis and Emerman, 1994; Roe et al., 1993). Cells 
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arrested in G1/G0 or G2 phase are not susceptible to MLV infection (Miller et al., 1990; 
Varmus et al., 1977), and the viral core only has access to the nucleoplasm when the 
nuclear membrane is broken down during mitosis. The p12 protein has been shown to 
tether the PIC to mitotic chromosomes (Elis et al., 2012). 
          In the PIC, several nucleotides at the 3’ end of both strand of viral DNA are cleaved 
off by IN, in an reaction called 3’-end processing. Once inside the nucleus, the PIC targets 
the host DNA and the DNA with 3’-recessed end attacks the phosphate of cellular DNA, 
which is called strand transfer. The integration process is completed when DNA repair 
enzymes fill the gaps between viral DNA and host DNA, which ensures the viral DNA 
becomes a permanent residence of the host cell genome. Viral DNAs that are not 
integrated into host genome will form circular DNAs, which serve as a marker of nuclear 
entry (Gianni et al., 1975; Roth et al., 1990).  
1.4.2. Late events 
          The early events result in the permanent integration of the viral DNA into the host 
chromosome, forming the provirus. This DNA serves as the template to express genomic 
RNA and messenger RNA and produce viral protein to assemble new virus for next round 
of infection. The late events include transcription of the provirus, splicing and transport of 
viral RNAs, translation to make precursor proteins, packaging of viral genome and 
assembly of virion, budding and maturation of viruses (Figure 3). 
         The provirus employs host transcription machinery to make viral RNAs. The U3 
region contains the promoter and enhancer for transcription. The RNA is 5’ capped and 
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then transcribed and finally cleaved and polyadenylated at the R-5 border of 3’ LTR, 
which results in an unspliced genomic RNA that is suitable for packaging into viral 
particles.  
          Most cellular mRNAs undergo complete splicing before being transported into 
cytoplasm. Transport to the cytoplasm is prevented before splicing is completed. So 
retroviruses must develop some mechanism to export unspliced or intron-containing 
RNAs into cytoplasm, which serve as genomic RNA for packaging or mRNA for making 
the Gag and Gag-Pol precursor proteins (Pollard and Malim, 1998). Unspliced RNA is 
believed to contain constitutive export elements (CTE) to promote the export (Bray et al., 
1994). For MLV, the CTE is thought to lie in the gag region (King et al., 1998). The 
intron-containing mRNAs of HIV-1 contain a cis-acting element, called the Rev response 
element (RRE), which is responsible for the export of unspliced mRNAs.  
          The exported mRNAs of MLV have three destinations: to be translated to make Gag 
and Gag-Pol proteins,to be spliced to make Env glycoprotein, and to be packaged into 
virion as genomic RNA. The RNA is incorporated into virions by interactions between the 
packaging element, Psi, and the NC domain of Gag (Bacharach and Goff, 1998; Berkowitz 
et al., 1996; Berkowitz et al., 1993; Berkowitz et al., 1995). 
         In the case of MLV, the gag and gag-pol coding sequences are in the same reading 
frame, and are separated by a UAG stop codon (Shinnick et al., 1981; Yoshinaka et al., 
1985) . The translation of the RNA results in formation of the Gag protein and 
approximately 10-20 fold lower levels of the Gag-Pol protein (Hatfield et al., 1992) . A 
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precise ratio of Gag:Gag-Pro-Pol protein is essential for assembly of retroviral virion 
(Felsenstein and Goff, 1988). A retroviral recoding sequence (Houck-Loomis et al., 2011) 
and interaction of RT and eRF1 (Orlova et al., 2003) participate in the suppression of 
translation termination at the Gag and Gag-pol boundary.  
          The Env glycoprotein is expressed from a spliced mRNA. The precursor protein is 
cleaved at the leader sequence and transferred to ER (Abeijon and Hirschberg, 1990). In 
the ER, the Env protein is glycosylated (Hirschberg and Snider, 1987), folded, presumably 
with the help of chaperones and oligomerized, which is required for the stable expression 
of the protein (Tucker et al., 1991). The Env protein is exported to the Golgi apparatus and 
cleaved into two domains, SU and TM (Dong, Dubay et al. 1992), and then transported to 
cellular surface via the host vesicular secretory pathway (Selig et al., 1999). 
          The virion assembly process begins once all viral precursor proteins, Gag, Gag-Pro-
Pol and Env, are synthesized. The assembly of MLV and HIV-1 takes place at the plasma 
membrane (Swanstrom and Wills, 1997). The major player of assembly is the Gag 
precursor polyprotein. Once the Gag precursor protein arrives at the plasma membrane, it 
is involved in three interactions, Gag-lipid, Gag-RNA and Gag-Gag, to promote the 
assembly of viral progeny. The MA domain is essential for the Gag-lipid interaction 
(Facke et al., 1993; Rowling et al., 1994). Myristylation of Gag has been shown to 
promote Gag-lipid interaction (Rein et al., 1986). The NC domain of Gag is important for 
the Gag-RNA and Gag-gag interaction (Krishnan and Pueppke, 1998; Zhang et al., 1996). 
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          Retroviral budding usually recruits cellular factors involved in creating vesicles in a 
late endosomal compartment called the multivesicular body (MVB), indicating that the 
budding process might be analogous to MVB process (Garrus et al., 2001; Patnaik et al., 
2000). Retroviruses can also bud into the endosomal membrane and exit at the sites of 
cell-cell contact (Sherer et al., 2003). Mutational analysis revealed that a proline-rich motif 
Pro-Pro-Pro-Tyr (PPPY) of p12 is required for efficient budding (Yuan et al., 2000; Yuan 
et al., 1999). Mutations in the PPPY motif result in mutant particles that fail to detach 
from the virus-expressing cell and remain attached to the plasma membrane (Gottlinger et 
al., 1991; Huang et al., 1995). After budding, the immature virion is processed by PR to 
form infectious virus. Mutant PR will result in immature viral particles that are not 
infectious (Katoh et al., 1985).  
1.5.Host restriction factors 
          Retroviruses are very successful pathogens that infect virtually all branches of life. 
Host cells have evolved mechanisms that block or negatively regulate the replication of 
retroviruses under tremendous selection pressure. These mechanisms function at almost 
every step of retroviral replication (Figure 5) (Goff, 2004; Wolf and Goff, 2008). However, 
retroviruses, in turn, have evolved mechanisms to inactivate or overcome the host block of 
replication. By way of introduction, several factors, APOBECs, Trim5α, ZAP, Trim28, 
Tetherin and SLFN11 will be discussed briefly.  
          The role of the APOBEC proteins in restricting HIV-1 was discovered during 
studies of the viral infectivity factor (Vif) , one of the accessory proteins. The replication 
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of HIV-1 in “permissive” cell lines, such as CEM-SS and SupT1, is Vif independent but in 
non-permissive cell lines, such as primary CD4+ T-cells and monocyte-derived 
macrophages, is dependent on Vif (Fisher et al., 1987; Gabuzda et al., 1992; Sakai et al., 
1993; Sova and Volsky, 1993; Strebel et al., 1987).  Vif-minus virions produced in non-
permissive cells are poorly infectious, but Vif-minus virions produced in permissive cells 
are able to infect both permissive and non-permissive cells (Gabuzda et al., 1992; Sakai et 
al., 1993; Strebel et al., 1987), which indicates that there is an antiviral factor in non-
permissive cells that Vif can neutralize (Madani and Kabat, 1998; Simon et al., 1998).  
The factor was identified by screening transcripts from non-permissive cells eventually 
leading to the isolation of APOBEC3G, a cytidine deaminase enzyme (Sheehy et al., 
2002). APOBEC3G has been shown to be recruited into HIV-1 virion by interaction with 
NC domain (Alce and Popik, 2004; Cen et al., 2004) and to introduce C to T mutations in 
the minus strand of viral DNA, producing G to A mutations in the plus strand (Harris et al., 
2003; Mangeat et al., 2003; Zhang et al., 2003), which disrupt the replication of the virus. 
The block is overcome by Vif-mediated proteasomal degradation of APOBEC3G 
(Conticello et al., 2003; Liu et al., 2004; Marin et al., 2003). The replication of MLV is not 
blocked by APOBEC3G, which is believed to be inactivated by MLV PR, although it was 
shown to be incorporated into MLV virions (Abudu et al., 2006; Douaisi et al., 2004; 
Mariani et al., 2003).  
          The Trim5α protein contains three domains: a RING domain, one or two B-boxes, 
and a coiled-coiled domain (Nisole et al., 2005). The RING domain is usually found in E3 
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ligases, and there is evidence suggesting that Trim5α is an E3 ligase (Diaz-Griffero et al., 
2006; Xu et al., 2003).  The B-boxes are interaction domains, which determine the 
substrate specificity of the E3 ligase activity (Massiah et al., 2007; Massiah et al., 2006). 
The coiled-coiled domain is responsible for the homo- and hetromultimerization of Trim 
proteins (Peng et al., 2000; Reymond et al., 2001). There is a B30.2 domain in the C 
terminus of Trim5α which binds to the CA domain of retroviruses and determines the 
restriction specificity (Hatziioannou et al., 2004; Nakayama et al., 2005; Perez-Caballero 
et al., 2005; Perron et al., 2004; Sebastian and Luban, 2005; Stremlau et al., 2006; 
Stremlau et al., 2005). Species variation in the B30.2 domain of Trim5α leads to their 
different ability to restrict HIV-1 and other retroviruses (Sawyer et al., 2005; Schaller et al., 
2007; Stremlau et al., 2004). For example, rhesus macaque Trim5α restricts HIV-1, and N-
tropic MLV but not SIVmac, whereas human Trim5α blocks N-tropic MLV but not B-
tropic MLV, HIV-1 and SIVmac (Hatziioannou et al., 2004; Perez-Caballero et al., 2005; 
Sawyer et al., 2005; Song et al., 2005; Stremlau et al., 2004; Yap et al., 2004). The 
mechanism that Trim5α uses to restrict retroviruses is still to be fully illuminated. Trim5a 
is likely to block early steps of the replication cycle of retrovirus, specifically after viral 
entry and before reverse transcription (Anderson et al., 2006; Himathongkham and Luciw, 
1996; Shibata et al., 1995; Wu et al., 2006). The effects might be due to the E3 ligases 
activity which leads to the proteasomal degradation of CA and other viral proteins 
(Anderson et al., 2006; Wu et al., 2006). However, it has been shown that Trim5α also 
mediates proteasomal-independent degradation of viral proteins (Chatterji et al., 2006).  
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          The zinc finger antiviral protein (ZAP) was identified in a screen of cells 
overexpressing a cDNA library in Rat2 cells and searching for dominant-acting factors 
restricting viral infection (Gao et al., 2002). The ZAP protein contains four CCCH-type 
zinc fingers, which are found in a small group of RNA binding proteins known as the 
tristetraprolin (TTP) tandem zinc finger (TZF) family (Lai et al., 2000). It has been shown 
that members of TZF family bind specifically to the AU-rich element (ARE) of 3’ 
untranslated region of several cytokine RNAs and lead to their degradation (Carballo et al., 
1998, 2000; Lai et al., 1999). This immediately suggested that ZAP might similarly bind 
RNA elements of retroviruses. It was indeed found that ZAP binds to the 3’LTR of MLV 
and blocks the accumulation of viral RNA in cytoplasm (Gao et al., 2002; Guo et al., 
2004). Mutations in CCCH zinc fingers, which abolish the interaction between ZAP and 
viral RNA, lead to the loss of antiviral activity of ZAP (Gao et al., 2002).  ZAP has also 
been shown to block the replication of other viruses, such as Sindbis virus (Bick et al., 
2003; Guo et al., 2004; Zhang et al., 2007) and Ebola virus (Muller et al., 2007). ZAP 
interacts with components of the RNA exosome and mediates the degradation of viral 
mRNAs (Guo et al., 2007). A recent study showed that ZAP also interferes with the 
function of translational initiation factors, leading to the translational repression of viral 
mRNA, which surprisingly is required for the degradation of viral mRNA (Zhu et al., 
2012).      
        Besides Trim5α, another Trim family protein, Trim28, was shown to be involved in 
the transcriptional silencing of retroelements, including exogenous and endogenous 
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retroviruses, in stem cells (Fasching et al., 2015; Rowe et al., 2010; Wolf and Goff, 2007). 
The major mechanism of action of Trim28 in retroviral silencing is through its ability to 
interact with Krab-box containing zinc finger proteins and many transcriptional repression 
factors (Iyengar and Farnham, 2011). Details of retroviral replication in stem cells will be 
discussed in the following section. Recently TRIM28Trim28 has also been shown to 
interact with acetylated Integrase of HIV-1 and mediate its deacetylation through 
interfering with HDAC1, which prevents the integration of HIV-1 (Allouch et al., 2011).  
          Like APOBEC3G, Tetherin was identified as a restriction factor by studying another 
HIV-1 accessary protein, Vpu (Neil et al., 2008; Van Damme et al., 2008). Tetherin is 
only effective against Vpu-minus HIV-1 virions (Varthakavi et al., 2003). Expressing 
tetherin in cells producing Vpu-minus virions results in the accumulation of fully formed 
and infectious virions bound to the extracellular leaflet of outer cell membrane (Neil et al., 
2007). Tetherin is upregulated upon stimulation of interferon alpha (IFNα), and 
specifically inhibits Vpu-minus HIV-1 virions but not wild-type ones (Neil et al., 2008). 
Tetherin is a membrane protein with unique topology, including an N-terminal 
cytoplasmic tail, a membrane-spanning helix, an extracellular coiled-coiled domain and a 
C-terminal glycosylphosphatidylinositol (GPI) anchor (Kupzig et al., 2003; Rollason et al., 
2007).  It is hypothesized that tetherin bridges an interaction between the cellular 
membrane and the viral envelope with one of its two lipid-bilayer anchoring domains 
(Neil et al., 2007). The mechanism by which Vpu agonizes tetherin is not fully understood. 
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It has been shown that expressing Vpu could down-regulate tetherin from extracellular 
membranes through a proteasomal independent manner (Van Damme et al., 2008).  
          Schlafen 11 (SLFN11) is novel retroviral restriction factor that was discovered 
recently (Li et al., 2012). In mammals, the induction of interferon pathway is an important 
part of antiviral activity upon viral infection. SLFN gene is a subset of interferon-
stimulated genes (ISGs) and  induced by the interferon regulatory factor 3 (IRF3) pathway 
after pathogen infection (Sohn et al., 2007).  SLFN11, which specifically abrogates the 
production of retroviruses, does not affect the early steps of retroviral replication, 
including reverse transcription, integration and transcription. It interacts with tRNAs and 
counteracts changes of tRNA pools elicited by presence of retroviruses, which disrupts the 
codon-usage of retroviruses and impair the production of viral proteins (Li et al., 2012).  
          In summary, the innate immunity of retroviral infection takes place almost in every 
step of viral replication. Correspondingly, retroviruses have evolved different kinds of 
mechanisms to evade the restriction from host factors for successful infection.  
1.6.Activities of retroviruses and retrotransposons in different cell types 
Retroviruses that infect germ cells or early embryos can introduce their DNA into 
the germ line and thereby become  endogenous retroviruses (Wicker et al., 2007). About 8% 
of human genome and 10% of mouse genome are made up of endogenous retroviruses 
(Lander et al., 2001; McCarthy and McDonald, 2004). 
        Retrotransposons are genetic elements that can replicate themselves in a genome 
through RNA intermediates. They are very similar to retroviruses except that 
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retrotransposons do not bud from cells and infect other cells. Retrotransposons can induce 
mutation in genomes by insertion. In fact, 42% of human genome is composed of 
retrotransposons (Lander et al., 2001). Most of the retrotransposons are not active due to 
the accumulation of mutations. The replication of retrotransposons is tightly regulated 
during development (Figure 6). There are two types of retrotransposons, those with long 
terminal repeats (LTR) or without long terminal repeat (non-LTR) (Figure 7). LTR 
retrotransposons have LTRs ranging in size from 100 bps to 5 kbps. Non-LTR 
retrotransposons are composed of two subgroups, long interspersed elements (LINEs) and 
short interspersed elements (SINEs) (Singer, 1982).  
The replication patterns of retroviruses and retrotransposons in stem cells and 
differentiated cells are different. LINEs or L1s make up 17% of human genome and only 
0.1%-0.2% of those are capable of mobility (Brouha et al., 2003; Cordaux and Batzer, 
2009; Doucet et al., 2010).  L1 codes two proteins, ORF1 and ORF2, which is flanked by 
two untranslated regions (UTR) (Cordaux and Batzer, 2009). ORF1 is a RNA binding 
protein and ORF2 has reverse transcriptase and endonuclease activities, which are similar 
to the Gag and Pol proteins of retroviruses respectively (Ohshima and Okada, 2005). 
SINEs, composing 11% of human genome, do not encode function reverse transcriptase, 
and its mobility is dependent on other retroelements (Cordaux and Batzer, 2009; 
Santangelo et al., 2007).  
          Endogenous retroviruses (ERV) are the remnant of previous retroviral infection 
(Rahm et al., 2011). For most ERVs, extinction is their final fate but some of the ERVs are 
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still capable of mobility and replication. In mouse genome, there are several active ERVs, 
and in contrast, most of ERVs in the human genome are defective (Stocking and Kozak, 
2008). The expression patterns of ERVs seem to be cell-type specific or developmental 
stage dependent (Figure 7) (Dupressoir and Heidmann, 1996; Spence et al., 1989; Taruscio 
and Mantovani, 2004).  In 2-cell embryos, many transcripts are initiated from the LTR of 
ERVs, which might cause the stem cell potency fluctuation along with the activity of 
endogenous retroviruses (Macfarlan et al., 2012). A subgroup of human ERVs, the HERV-
H family, was shown to be important for stem cell renewal (Wang et al., 2014b). ERV 
activities are also detectable in germ cells but later silenced during differentiation (Matzke 
et al., 2000; Peaston et al., 2004; Slotkin and Martienssen, 2007). It has been demonstrated 
that the expression of ERVs is regulated by many cellular factors, including Trim28 
(Rowe et al., 2010), ESET, DNA methylation enzymes, histone acetylation enzymes and 
small RNAs (Rowe and Trono, 2011).  
          The frequency of L1 activities in different cell types is different. L1 RNA and 
proteins are predominantly found in germ cells and infrequently in differentiated tissues 
(Branciforte and Martin, 1994; Trelogan and Martin, 1995). In vivo studies using mouse 
models have shown that L1 retrotransposition activities are high in germ cells, in early 
embryo development and some somatic cells (Martin and Branciforte, 1993; Muotri et al., 
2005; Ostertag et al., 2002). In vitro L1 retrotransposition assays have suggest that L1 
mobilizes in a variety of human and rodent transformed cells (Moran et al., 1996), human 
embryonic stem cells (Garcia-Perez et al., 2007) and neuron progenitor cells (Muotri et al., 
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2005)  but relatively rarely in human fibroblasts (Shi et al., 2007) and embryonic 
carcinoma cells (Garcia-Perez et al., 2010). L1 can serve as a mutagen which result in 
diseases in mammals (Beck et al., 2011; Kazazian et al., 1988) or as a genomic diversifier, 
which is important for generating genetic diversity and plasticity of neurons and perhaps 
for broadening the spectrum of behavior phenotypes (Singer et al., 2010).        
          Similar to ERVs, exogenous retroviruses are tightly controlled by cellular 
machineries. MLV replicates efficiently in most dividing cells but is blocked in mouse ES 
and EC cells (Barklis et al., 1986; Teich et al., 1977).  The infected viruses can integrate 
into the host genome, but transcription from the viral LTR is restricted by trans-acting 
repressive factors (Akgun et al., 1991; Flanagan et al., 1989).  The major target of these 
repressive factors is the repressor binding site (RBS), which overlap with the PBS of 
proviral DNA (Feuer et al., 1989; Loh et al., 1990).  The RBS acts in an orientation and 
position-independent manner (Feuer et al., 1989; Petersen et al., 1991). Our lab identified 
two key components of the repression complex, ZFP809 and Trim28. ZFP809 is a KRAB 
box containing zinc-finger protein which binds directly to the RBS and initiates the 
silencing (Wolf and Goff, 2007, 2009). Expression of ZFP809 alone in differentiated cells 
is sufficient to establish the silencing. It recruits Trim28 and other transcription repressors 
to silence the transcription of viral genes through placing epigenetic marks on the viral 
chromatin (Schlesinger and Goff, 2015; Wolf et al., 2008). It has been shown that there are 
other factors in the silencing complex to mediate full repression of viral transcription 
(Wang et al., 2014a).          
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1.7.Dissertation Road map 
          Retroviral replication is silenced in ES and EC cells by a trans-acting silencing 
complex, but is not silenced in most differentiated cells. In Chapter 2, the mechanism of 
regulation of retroviral silencing in differentiated cells will be discussed.   
          Since ZFP809 is the crucial factor that initiates the silencing of MLV, the mRNA 
level of ZFP809 was examined by comparing the expression profiles in available 
databases and as determined by semi-quantitative PCR. Interestingly, the mRNA levels of 
ZFP809 in differentiated cells and embryonic cells are comparable. Protein degradation 
assays showed that ZFP809 is degraded rapidly in differentiated cells.  We noted the 
existence of two forms of ZFP809: a longer, full-length protein and a shorter, C-terminally 
truncated protein ZFP(1-353). A single lysine residue in the C-terminal region of the full-
length ZFP809 protein is important for the turnover of ZFP809. The degradation of 
ZFP809 is subject to the ubiquitin-dependent proteasomal pathway. The C-terminal 
truncation form of ZFP809, ZFP809(1-353), is somewhat more stable in differentiated 
cells. Overall, our observations suggest that rapid depletion of ZFP809 proteins by the 
proteasomal system in differentiated cells result in the loss of retroviral repression in those 
cells.  
          In Chapter 3, we studied the function of a novel protein, L1td1, on retroviral 
silencing in embryonic cells. L1td1 was identified in the set of proteins that interact with 
Trim28 during purification of the silencing complex. Immunoprecipitation assays showed 
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that L1td1 interacts with both ZFP809 and Trim28. Depletion of L1td1 using shRNAs 
partially relieves the restriction from RBS.  
          An overall discussion of regulation of retroviral silencing in different types of cells 
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Figure 1 Organization of the Moloney murine leukemia virus (MLV) genome. 
The gag gene encodes structural proteins, pol encoding enzymes and env encoding 
the glycoprotein. The 5' LTR promoter drives transcription of both full length 
genomic and spliced mRNAs. Poly protein precussors gag and gag-pol are 
synthesized form the unspliced mRNA and env protein from spliced mRNA. The 
Gag and Gag-Pol polyproteins are cleaved and matured by the viral protease, while 
Env is processed by cellular proteases. The Gag precusser is cleaved into matrix 
(MA), p12, capsid (CA) and nucleocapsid (NC); Gag-pol, protease (PR), reverse 
transcriptase (RT) and integrase (IN); Env, surface (SU) and transmembrane (TM) 
























Figure 2 The organization of MLV genome and virion.   
A) Viral proteins encoded by viral genes. The gag gene encodes MA, p12, 
CA and NC; the pol gene encodes PR, RT and IN and the env gene 
encodes SU and TM. B) Condensation of MLV. The maturation process of 
MLV was observed by the electron microscopy. C) The structural scheme 




Figure 3 Graphical representation of retroviral replication cycle.  
The early phase contains processes that before establishment of integrated 
proviral DNA, including ① attachment and entry, ② uncoating, ③reverse 
transcription, ④ transportation and ⑤ integration. Late stage begins with 
⑥ viral transcription and continues with ⑦ ⑨ ⑩nuclear export of 
spliced and unspliced viral RNAs, ⑧ ⑪translation of gag precursor and 
env genes, ⑫ modification of env proteins, ⑬ ⑭ packaging and 




   
 
Figure 4 Steps of reverse transcription.  
Reverse transcription is initiated by the Proline tRNA binding 
to the PBS. A series of Rnase H and DNA synthesase activities 
are undergoing to convert the single-stranded RNA to double-










Figure 5 Host restriction factors block different steps of retroviral replication.  
APOBEC involves in the reverse transcription step. Trim5α inhibits reverse 
transcription or nuclear entry. Trim28 blocks transcription. ZAP interacts with 
viral RNAs. SLFN11 inhibit the translation of proteins and tetherin inhibits 
























Figure 6 Expression and methylation pattern of endogenous retrotransposons.  
DNA methylation of IAPs reach their lowest level of around 62% at E3.5 stage, 
still considerably higher than Line1s that drop to around 25% methylation. There 
is another peak of demethylation at stage of E11.5. The middle figures show the 
peak activities of different retrotransposons in different development stage. The 
factors at the bottom are known to be important in ERV regulation are shown 





Figure 7 Structure scheme of retrotransposons.  
This figure is adapted from (Wicker et al., 2007). Non-LTR retrotransposons encodes 
proteins retains the structure (ORF) and enzymatic functions (reverse transcriptase RT, 
Rnase H RH and integrase INT). There are two types of LTR retrotransposons, one 
with Env gene such as endogenous retrovirus and the other is Ty3 like retrotransposons 














Abeijon, C., and Hirschberg, C.B. (1990). Topography of initiation of N-glycosylation 
reactions. The Journal of biological chemistry 265, 14691-14695. 
Abudu, A., Takaori-Kondo, A., Izumi, T., Shirakawa, K., Kobayashi, M., Sasada, A., 
Fukunaga, K., and Uchiyama, T. (2006). Murine retrovirus escapes from murine 
APOBEC3 via two distinct novel mechanisms. Current biology : CB 16, 1565-1570. 
Akgun, E., Ziegler, M., and Grez, M. (1991). Determinants of retrovirus gene expression 
in embryonal carcinoma cells. Journal of virology 65, 382-388. 
Albritton, L.M., Kim, J.W., Tseng, L., and Cunningham, J.M. (1993). Envelope-binding 
domain in the cationic amino acid transporter determines the host range of ecotropic 
murine retroviruses. Journal of virology 67, 2091-2096. 
Alce, T.M., and Popik, W. (2004). APOBEC3G is incorporated into virus-like particles by 
a direct interaction with HIV-1 Gag nucleocapsid protein. The Journal of biological 
chemistry 279, 34083-34086. 
Alin, K., and Goff, S.P. (1996). Amino acid substitutions in the CA protein of Moloney 
murine leukemia virus that block early events in infection. Virology 222, 339-351. 
Allouch, A., Di Primio, C., Alpi, E., Lusic, M., Arosio, D., Giacca, M., and Cereseto, A. 
(2011). The TRIM family protein KAP1 inhibits HIV-1 integration. Cell host & microbe 9, 
484-495. 
Anderson, J.L., Campbell, E.M., Wu, X., Vandegraaff, N., Engelman, A., and Hope, T.J. 
(2006). Proteasome inhibition reveals that a functional preintegration complex 
intermediate can be generated during restriction by diverse TRIM5 proteins. Journal of 
virology 80, 9754-9760. 
Anson, D.S. (2004). The use of retroviral vectors for gene therapy-what are the risks? A 
review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene 
delivery. Genetic vaccines and therapy 2, 9. 
33 
 
Auerbach, M.R., Shu, C., Kaplan, A., and Singh, I.R. (2003). Functional characterization 
of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting. 
Proceedings of the National Academy of Sciences of the United States of America 100, 
11678-11683. 
Bacharach, E., and Goff, S.P. (1998). Binding of the human immunodeficiency virus type 
1 Gag protein to the viral RNA encapsidation signal in the yeast three-hybrid system. 
Journal of virology 72, 6944-6949. 
Barklis, E., Mulligan, R.C., and Jaenisch, R. (1986). Chromosomal position or virus 
mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47, 391-399. 
Beck, C.R., Garcia-Perez, J.L., Badge, R.M., and Moran, J.V. (2011). LINE-1 elements in 
structural variation and disease. Annual review of genomics and human genetics 12, 187-
215. 
Berger, E.A., Murphy, P.M., and Farber, J.M. (1999). Chemokine receptors as HIV-1 
coreceptors: roles in viral entry, tropism, and disease. Annual review of immunology 17, 
657-700. 
Berkowitz, R., Fisher, J., and Goff, S.P. (1996). RNA packaging. Current topics in 
microbiology and immunology 214, 177-218. 
Berkowitz, R.D., Luban, J., and Goff, S.P. (1993). Specific binding of human 
immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs 
detected by RNA mobility shift assays. Journal of virology 67, 7190-7200. 
Berkowitz, R.D., Ohagen, A., Hoglund, S., and Goff, S.P. (1995). Retroviral nucleocapsid 
domains mediate the specific recognition of genomic viral RNAs by chimeric Gag 
polyproteins during RNA packaging in vivo. Journal of virology 69, 6445-6456. 
Bick, M.J., Carroll, J.W., Gao, G., Goff, S.P., Rice, C.M., and MacDonald, M.R. (2003). 
Expression of the zinc-finger antiviral protein inhibits alphavirus replication. Journal of 
virology 77, 11555-11562. 
34 
 
Bobardt, M.D., Saphire, A.C., Hung, H.C., Yu, X., Van der Schueren, B., Zhang, Z., 
David, G., and Gallay, P.A. (2003). Syndecan captures, protects, and transmits HIV to T 
lymphocytes. Immunity 18, 27-39. 
Bowerman, B., Brown, P.O., Bishop, J.M., and Varmus, H.E. (1989). A nucleoprotein 
complex mediates the integration of retroviral DNA. Genes & development 3, 469-478. 
Branciforte, D., and Martin, S.L. (1994). Developmental and cell type specificity of LINE-
1 expression in mouse testis: implications for transposition. Molecular and cellular biology 
14, 2584-2592. 
Bray, M., Prasad, S., Dubay, J.W., Hunter, E., Jeang, K.T., Rekosh, D., and Hammarskjold, 
M.L. (1994). A small element from the Mason-Pfizer monkey virus genome makes human 
immunodeficiency virus type 1 expression and replication Rev-independent. Proceedings 
of the National Academy of Sciences of the United States of America 91, 1256-1260. 
Brouha, B., Schustak, J., Badge, R.M., Lutz-Prigge, S., Farley, A.H., Moran, J.V., and 
Kazazian, H.H., Jr. (2003). Hot L1s account for the bulk of retrotransposition in the 
human population. Proceedings of the National Academy of Sciences of the United States 
of America 100, 5280-5285. 
Carballo, E., Lai, W.S., and Blackshear, P.J. (1998). Feedback inhibition of macrophage 
tumor necrosis factor-alpha production by tristetraprolin. Science 281, 1001-1005. 
Carballo, E., Lai, W.S., and Blackshear, P.J. (2000). Evidence that tristetraprolin is a 
physiological regulator of granulocyte-macrophage colony-stimulating factor messenger 
RNA deadenylation and stability. Blood 95, 1891-1899. 
Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., and Kleiman, L. (2004). The 
interaction between HIV-1 Gag and APOBEC3G. The Journal of biological chemistry 279, 
33177-33184. 
Chatterji, U., Bobardt, M.D., Gaskill, P., Sheeter, D., Fox, H., and Gallay, P.A. (2006). 
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 
entry. The Journal of biological chemistry 281, 37025-37033. 
35 
 
Coffin, J.M., Hughes, S.H., and Varmus, H.E. (1997). The Interactions of Retroviruses 
and their Hosts. In Retroviruses, J.M. Coffin, S.H. Hughes, and H.E. Varmus, eds. (Cold 
Spring Harbor (NY)). 
Conticello, S.G., Harris, R.S., and Neuberger, M.S. (2003). The Vif protein of HIV 
triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Current 
biology : CB 13, 2009-2013. 
Cordaux, R., and Batzer, M.A. (2009). The impact of retrotransposons on human genome 
evolution. Nature reviews Genetics 10, 691-703. 
Craven, R.C., Leure-duPree, A.E., Weldon, R.A., Jr., and Wills, J.W. (1995). Genetic 
analysis of the major homology region of the Rous sarcoma virus Gag protein. Journal of 
virology 69, 4213-4227. 
Crawford, S., and Goff, S.P. (1984). Mutations in gag proteins P12 and P15 of Moloney 
murine leukemia virus block early stages of infection. Journal of virology 49, 909-917. 
Crawford, S., and Goff, S.P. (1985). A deletion mutation in the 5' part of the pol gene of 
Moloney murine leukemia virus blocks proteolytic processing of the gag and pol 
polyproteins. Journal of virology 53, 899-907. 
Diaz-Griffero, F., Li, X., Javanbakht, H., Song, B., Welikala, S., Stremlau, M., and 
Sodroski, J. (2006). Rapid turnover and polyubiquitylation of the retroviral restriction 
factor TRIM5. Virology 349, 300-315. 
Douaisi, M., Dussart, S., Courcoul, M., Bessou, G., Vigne, R., and Decroly, E. (2004). 
HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like 
particles. Biochemical and biophysical research communications 321, 566-573. 
Doucet, A.J., Hulme, A.E., Sahinovic, E., Kulpa, D.A., Moldovan, J.B., Kopera, H.C., 
Athanikar, J.N., Hasnaoui, M., Bucheton, A., Moran, J.V., et al. (2010). Characterization 
of LINE-1 ribonucleoprotein particles. PLoS genetics 6. 
36 
 
Dupressoir, A., and Heidmann, T. (1996). Germ line-specific expression of intracisternal 
A-particle retrotransposons in transgenic mice. Molecular and cellular biology 16, 4495-
4503. 
Elis, E., Ehrlich, M., Prizan-Ravid, A., Laham-Karam, N., and Bacharach, E. (2012). p12 
tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS 
pathogens 8, e1003103. 
Facke, M., Janetzko, A., Shoeman, R.L., and Krausslich, H.G. (1993). A large deletion in 
the matrix domain of the human immunodeficiency virus gag gene redirects virus particle 
assembly from the plasma membrane to the endoplasmic reticulum. Journal of virology 67, 
4972-4980. 
Fasching, L., Kapopoulou, A., Sachdeva, R., Petri, R., Jonsson, M.E., Manne, C., Turelli, 
P., Jern, P., Cammas, F., Trono, D., et al. (2015). TRIM28 Represses Transcription of 
Endogenous Retroviruses in Neural Progenitor Cells. Cell reports 10, 20-28. 
Fassati, A., and Goff, S.P. (1999). Characterization of intracellular reverse transcription 
complexes of Moloney murine leukemia virus. Journal of virology 73, 8919-8925. 
Felsenstein, K.M., and Goff, S.P. (1988). Expression of the gag-pol fusion protein of 
Moloney murine leukemia virus without gag protein does not induce virion formation or 
proteolytic processing. Journal of virology 62, 2179-2182. 
Feuer, G., Taketo, M., Hanecak, R.C., and Fan, H. (1989). Two blocks in Moloney murine 
leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined 
by transient expression assays. Journal of virology 63, 2317-2324. 
Fisher, A.G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, 
R.C., and Wong-Staal, F. (1987). The sor gene of HIV-1 is required for efficient virus 
transmission in vitro. Science 237, 888-893. 
Flanagan, J.R., Krieg, A.M., Max, E.E., and Khan, A.S. (1989). Negative control region at 




Flint, S.J., Enquist, L.W., Krug, R.M., Racaniello, V.R., and Skalka, A.M. (2000). 
Principles of Virology: Molecular Biology, Pathogenesis, and Control (Washington, D.C.: 
ASM Press). 
Gabuzda, D.H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W.A., 
and Sodroski, J. (1992). Role of vif in replication of human immunodeficiency virus type 
1 in CD4+ T lymphocytes. Journal of virology 66, 6489-6495. 
Gao, G., Guo, X., and Goff, S.P. (2002). Inhibition of retroviral RNA production by ZAP, 
a CCCH-type zinc finger protein. Science 297, 1703-1706. 
Garcia-Perez, J.L., Marchetto, M.C., Muotri, A.R., Coufal, N.G., Gage, F.H., O'Shea, K.S., 
and Moran, J.V. (2007). LINE-1 retrotransposition in human embryonic stem cells. 
Human molecular genetics 16, 1569-1577. 
Garcia-Perez, J.L., Morell, M., Scheys, J.O., Kulpa, D.A., Morell, S., Carter, C.C., 
Hammer, G.D., Collins, K.L., O'Shea, K.S., Menendez, P., et al. (2010). Epigenetic 
silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. 
Nature 466, 769-773. 
Garrus, J.E., von Schwedler, U.K., Pornillos, O.W., Morham, S.G., Zavitz, K.H., Wang, 
H.E., Wettstein, D.A., Stray, K.M., Cote, M., Rich, R.L., et al. (2001). Tsg101 and the 
vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65. 
Gianni, A.M., Smotkin, D., and Weinberg, R.A. (1975). Murine leukemia virus: detection 
of unintegrated double-stranded DNA forms of the provirus. Proceedings of the National 
Academy of Sciences of the United States of America 72, 447-451. 
Goff, S.P. (2004). Genetic control of retrovirus susceptibility in mammalian cells. Annual 
review of genetics 38, 61-85. 




Gonsky, J., Bacharach, E., and Goff, S.P. (2001). Identification of residues of the Moloney 
murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo. Journal of 
virology 75, 2616-2626. 
Gottlinger, H.G., Dorfman, T., Sodroski, J.G., and Haseltine, W.A. (1991). Effect of 
mutations affecting the p6 gag protein on human immunodeficiency virus particle release. 
Proceedings of the National Academy of Sciences of the United States of America 88, 
3195-3199. 
Granowitz, C., and Goff, S.P. (1994). Substitution mutations affecting a small region of 
the Moloney murine leukemia virus MA gag protein block assembly and release of virion 
particles. Virology 205, 336-344. 
Guo, X., Carroll, J.W., Macdonald, M.R., Goff, S.P., and Gao, G. (2004). The zinc finger 
antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger 
motifs. Journal of virology 78, 12781-12787. 
Guo, X., Ma, J., Sun, J., and Gao, G. (2007). The zinc-finger antiviral protein recruits the 
RNA processing exosome to degrade the target mRNA. Proceedings of the National 
Academy of Sciences of the United States of America 104, 151-156. 
Harris, R.S., Bishop, K.N., Sheehy, A.M., Craig, H.M., Petersen-Mahrt, S.K., Watt, I.N., 
Neuberger, M.S., and Malim, M.H. (2003). DNA deamination mediates innate immunity 
to retroviral infection. Cell 113, 803-809. 
Hatfield, D.L., Levin, J.G., Rein, A., and Oroszlan, S. (1992). Translational suppression in 
retroviral gene expression. Advances in virus research 41, 193-239. 
Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S., and Bieniasz, P.D. (2004). 
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. 
Proceedings of the National Academy of Sciences of the United States of America 101, 
10774-10779. 
Himathongkham, S., and Luciw, P.A. (1996). Restriction of HIV-1 (subtype B) replication 
at the entry step in rhesus macaque cells. Virology 219, 485-488. 
39 
 
Hirschberg, C.B., and Snider, M.D. (1987). Topography of glycosylation in the rough 
endoplasmic reticulum and Golgi apparatus. Annual review of biochemistry 56, 63-87. 
Houck-Loomis, B., Durney, M.A., Salguero, C., Shankar, N., Nagle, J.M., Goff, S.P., and 
D'Souza, V.M. (2011). An equilibrium-dependent retroviral mRNA switch regulates 
translational recoding. Nature 480, 561-564. 
Huang, M., Orenstein, J.M., Martin, M.A., and Freed, E.O. (1995). p6Gag is required for 
particle production from full-length human immunodeficiency virus type 1 molecular 
clones expressing protease. Journal of virology 69, 6810-6818. 
Iyengar, S., and Farnham, P.J. (2011). KAP1 protein: an enigmatic master regulator of the 
genome. The Journal of biological chemistry 286, 26267-26276. 
Jorgensen, E.C., Pedersen, F.S., and Jorgensen, P. (1992). Matrix protein of Akv murine 
leukemia virus: genetic mapping of regions essential for particle formation. Journal of 
virology 66, 4479-4487. 
Katen, L.J., Januszeski, M.M., Anderson, W.F., Hasenkrug, K.J., and Evans, L.H. (2001). 
Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs 
through an endocytic pathway. Journal of virology 75, 5018-5026. 
Katoh, I., Yoshinaka, Y., Rein, A., Shibuya, M., Odaka, T., and Oroszlan, S. (1985). 
Murine leukemia virus maturation: protease region required for conversion from 
"immature" to "mature" core form and for virus infectivity. Virology 145, 280-292. 
Kazazian, H.H., Jr., Wong, C., Youssoufian, H., Scott, A.F., Phillips, D.G., and 
Antonarakis, S.E. (1988). Haemophilia A resulting from de novo insertion of L1 
sequences represents a novel mechanism for mutation in man. Nature 332, 164-166. 
King, J.A., Bridger, J.M., Gounari, F., Lichter, P., Schulz, T.F., Schirrmacher, V., and 
Khazaie, K. (1998). The extended packaging sequence of MoMLV contains a constitutive 
mRNA nuclear export function. FEBS letters 434, 367-371. 
40 
 
Kizhatil, K., and Albritton, L.M. (1997). Requirements for different components of the 
host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis 
from entry via surface fusion. Journal of virology 71, 7145-7156. 
Krishnan, H.B., and Pueppke, S.G. (1998). Genetic characterization of a mutant of 
Sinorhizobium fredii strain USDA208 with enhanced competitive ability for nodulation of 
soybean, Glycine max (L.) Merr. FEMS microbiology letters 165, 215-220. 
Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G. (2003). 
Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. 
Traffic 4, 694-709. 
Lai, W.S., Carballo, E., Strum, J.R., Kennington, E.A., Phillips, R.S., and Blackshear, P.J. 
(1999). Evidence that tristetraprolin binds to AU-rich elements and promotes the 
deadenylation and destabilization of tumor necrosis factor alpha mRNA. Molecular and 
cellular biology 19, 4311-4323. 
Lai, W.S., Carballo, E., Thorn, J.M., Kennington, E.A., and Blackshear, P.J. (2000). 
Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related 
zinc finger proteins to Au-rich elements and destabilization of mRNA. The Journal of 
biological chemistry 275, 17827-17837. 
Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., 
Dewar, K., Doyle, M., FitzHugh, W., et al. (2001). Initial sequencing and analysis of the 
human genome. Nature 409, 860-921. 
Lazo, P.A., Lee, J.S., and Tsichlis, P.N. (1990). Long-distance activation of the Myc 
protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. 
Proceedings of the National Academy of Sciences of the United States of America 87, 
170-173. 
Lewis, P.F., and Emerman, M. (1994). Passage through mitosis is required for 




Li, M., Kao, E., Gao, X., Sandig, H., Limmer, K., Pavon-Eternod, M., Jones, T.E., Landry, 
S., Pan, T., Weitzman, M.D., et al. (2012). Codon-usage-based inhibition of HIV protein 
synthesis by human schlafen 11. Nature 491, 125-128. 
Liu, B., Yu, X., Luo, K., Yu, Y., and Yu, X.F. (2004). Influence of primate lentiviral Vif 
and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of 
APOBEC3G. Journal of virology 78, 2072-2081. 
Loh, T.P., Sievert, L.L., and Scott, R.W. (1990). Evidence for a stem cell-specific 
repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells. 
Molecular and cellular biology 10, 4045-4057. 
Lu, X., and Silver, J. (2000). Ecotropic murine leukemia virus receptor is physically 
associated with caveolin and membrane rafts. Virology 276, 251-258. 
Macfarlan, T.S., Gifford, W.D., Driscoll, S., Lettieri, K., Rowe, H.M., Bonanomi, D., Firth, 
A., Singer, O., Trono, D., and Pfaff, S.L. (2012). Embryonic stem cell potency fluctuates 
with endogenous retrovirus activity. Nature 487, 57-63. 
Madani, N., and Kabat, D. (1998). An endogenous inhibitor of human immunodeficiency 
virus in human lymphocytes is overcome by the viral Vif protein. Journal of virology 72, 
10251-10255. 
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003). Broad 
antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse 
transcripts. Nature 424, 99-103. 
Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., 
Nymark-McMahon, H., and Landau, N.R. (2003). Species-specific exclusion of 
APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31. 
Marin, M., Rose, K.M., Kozak, S.L., and Kabat, D. (2003). HIV-1 Vif protein binds the 
editing enzyme APOBEC3G and induces its degradation. Nature medicine 9, 1398-1403. 
42 
 
Martin, S.L., and Branciforte, D. (1993). Synchronous expression of LINE-1 RNA and 
protein in mouse embryonal carcinoma cells. Molecular and cellular biology 13, 5383-
5392. 
Massiah, M.A., Matts, J.A., Short, K.M., Simmons, B.N., Singireddy, S., Yi, Z., and Cox, 
T.C. (2007). Solution structure of the MID1 B-box2 CHC(D/C)C(2)H(2) zinc-binding 
domain: insights into an evolutionarily conserved RING fold. Journal of molecular 
biology 369, 1-10. 
Massiah, M.A., Simmons, B.N., Short, K.M., and Cox, T.C. (2006). Solution structure of 
the RBCC/TRIM B-box1 domain of human MID1: B-box with a RING. Journal of 
molecular biology 358, 532-545. 
Matsuoka, M. (2003). Human T-cell leukemia virus type I and adult T-cell leukemia. 
Oncogene 22, 5131-5140. 
Matzke, M.A., Mette, M.F., and Matzke, A.J. (2000). Transgene silencing by the host 
genome defense: implications for the evolution of epigenetic control mechanisms in plants 
and vertebrates. Plant molecular biology 43, 401-415. 
McCarthy, E.M., and McDonald, J.F. (2004). Long terminal repeat retrotransposons of 
Mus musculus. Genome biology 5, R14. 
McDonald, D., Vodicka, M.A., Lucero, G., Svitkina, T.M., Borisy, G.G., Emerman, M., 
and Hope, T.J. (2002). Visualization of the intracellular behavior of HIV in living cells. 
The Journal of cell biology 159, 441-452. 
Meiering, C.D., and Linial, M.L. (2001). Historical perspective of foamy virus 
epidemiology and infection. Clinical microbiology reviews 14, 165-176. 
Meric, C., and Goff, S.P. (1989). Characterization of Moloney murine leukemia virus 
mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid 
protein. Journal of virology 63, 1558-1568. 
43 
 
Miller, D.G., Adam, M.A., and Miller, A.D. (1990). Gene transfer by retrovirus vectors 
occurs only in cells that are actively replicating at the time of infection. Molecular and 
cellular biology 10, 4239-4242. 
Miller, D.G., and Miller, A.D. (1994). A family of retroviruses that utilize related 
phosphate transporters for cell entry. Journal of virology 68, 8270-8276. 
Mitchell, R.S., Beitzel, B.F., Schroder, A.R., Shinn, P., Chen, H., Berry, C.C., Ecker, J.R., 
and Bushman, F.D. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show 
distinct target site preferences. PLoS biology 2, E234. 
Moloney, J.B. (1960). Biological studies on a lymphoid-leukemia virus extracted from 
sarcoma 37. I. Origin and introductory investigations. Journal of the National Cancer 
Institute 24, 933-951. 
Moran, J.V., Holmes, S.E., Naas, T.P., DeBerardinis, R.J., Boeke, J.D., and Kazazian, 
H.H., Jr. (1996). High frequency retrotransposition in cultured mammalian cells. Cell 87, 
917-927. 
Muller, S., Moller, P., Bick, M.J., Wurr, S., Becker, S., Gunther, S., and Kummerer, B.M. 
(2007). Inhibition of filovirus replication by the zinc finger antiviral protein. Journal of 
virology 81, 2391-2400. 
Muotri, A.R., Chu, V.T., Marchetto, M.C., Deng, W., Moran, J.V., and Gage, F.H. (2005). 
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 
435, 903-910. 
Nakayama, E.E., Miyoshi, H., Nagai, Y., and Shioda, T. (2005). A specific region of 37 
amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha 
determines species-specific restriction of simian immunodeficiency virus SIVmac 
infection. Journal of virology 79, 8870-8877. 
Neil, S.J., Sandrin, V., Sundquist, W.I., and Bieniasz, P.D. (2007). An interferon-alpha-
induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is 
counteracted by the HIV-1 Vpu protein. Cell host & microbe 2, 193-203. 
44 
 
Neil, S.J., Zang, T., and Bieniasz, P.D. (2008). Tetherin inhibits retrovirus release and is 
antagonized by HIV-1 Vpu. Nature 451, 425-430. 
Nisole, S., and Saib, A. (2004). Early steps of retrovirus replicative cycle. Retrovirology 1, 
9. 
Nisole, S., Stoye, J.P., and Saib, A. (2005). TRIM family proteins: retroviral restriction 
and antiviral defence. Nature reviews Microbiology 3, 799-808. 
Ohshima, K., and Okada, N. (2005). SINEs and LINEs: symbionts of eukaryotic genomes 
with a common tail. Cytogenetic and genome research 110, 475-490. 
Orlova, M., Yueh, A., Leung, J., and Goff, S.P. (2003). Reverse transcriptase of Moloney 
murine leukemia virus binds to eukaryotic release factor 1 to modulate suppression of 
translational termination. Cell 115, 319-331. 
Ostertag, E.M., DeBerardinis, R.J., Goodier, J.L., Zhang, Y., Yang, N., Gerton, G.L., and 
Kazazian, H.H., Jr. (2002). A mouse model of human L1 retrotransposition. Nature 
genetics 32, 655-660. 
Palmer, M.T., Kirkman, R., Kosloff, B.R., Eipers, P.G., and Morrow, C.D. (2007). tRNA 
isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral 
translation. Journal of virology 81, 4397-4404. 
Patnaik, A., Chau, V., and Wills, J.W. (2000). Ubiquitin is part of the retrovirus budding 
machinery. Proceedings of the National Academy of Sciences of the United States of 
America 97, 13069-13074. 
Peaston, A.E., Evsikov, A.V., Graber, J.H., de Vries, W.N., Holbrook, A.E., Solter, D., 
and Knowles, B.B. (2004). Retrotransposons regulate host genes in mouse oocytes and 
preimplantation embryos. Developmental cell 7, 597-606. 
Peng, H., Begg, G.E., Schultz, D.C., Friedman, J.R., Jensen, D.E., Speicher, D.W., and 
Rauscher, F.J., 3rd (2000). Reconstitution of the KRAB-KAP-1 repressor complex: a 
45 
 
model system for defining the molecular anatomy of RING-B box-coiled-coil domain-
mediated protein-protein interactions. Journal of molecular biology 295, 1139-1162. 
Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S., and Bieniasz, P.D. (2005). 
Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and 
specificity. Journal of virology 79, 8969-8978. 
Perron, M.J., Stremlau, M., Song, B., Ulm, W., Mulligan, R.C., and Sodroski, J. (2004). 
TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human 
cells. Proceedings of the National Academy of Sciences of the United States of America 
101, 11827-11832. 
Petersen, R., Kempler, G., and Barklis, E. (1991). A stem cell-specific silencer in the 
primer-binding site of a retrovirus. Molecular and cellular biology 11, 1214-1221. 
Petropoulos, C.J. (1997). Retroviral Taxonomy, Protein Structures, Sequences and Genetic 
Maps, in Retroviruses (ed. J.M. Coffin, S.H. Hughes, and H.E. Varmus), (Cold Spring 
Harbor, NY: Cold Spring Harbor Laboratory Press). 
Pincus, T., Rowe, W.P., and Lilly, F. (1971). A major genetic locus affecting resistance to 
infection with murine leukemia viruses. II. Apparent identity to a major locus described 
for resistance to friend murine leukemia virus. The Journal of experimental medicine 133, 
1234-1241. 
Pizzato, M., Marlow, S.A., Blair, E.D., and Takeuchi, Y. (1999). Initial binding of murine 
leukemia virus particles to cells does not require specific Env-receptor interaction. Journal 
of virology 73, 8599-8611. 
Pollard, V.W., and Malim, M.H. (1998). The HIV-1 Rev protein. Annual review of 
microbiology 52, 491-532. 
Prizan-Ravid, A., Elis, E., Laham-Karam, N., Selig, S., Ehrlich, M., and Bacharach, E. 
(2010). The Gag cleavage product, p12, is a functional constituent of the murine leukemia 
virus pre-integration complex. PLoS pathogens 6, e1001183. 
46 
 
Rahm, N., Yap, M., Snoeck, J., Zoete, V., Munoz, M., Radespiel, U., Zimmermann, E., 
Michielin, O., Stoye, J.P., Ciuffi, A., et al. (2011). Unique spectrum of activity of 
prosimian TRIM5alpha against exogenous and endogenous retroviruses. Journal of 
virology 85, 4173-4183. 
Reicin, A.S., Paik, S., Berkowitz, R.D., Luban, J., Lowy, I., and Goff, S.P. (1995). Linker 
insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on 
virion particle assembly, release, and infectivity. Journal of virology 69, 642-650. 
Rein, A., Harvin, D.P., Mirro, J., Ernst, S.M., and Gorelick, R.J. (1994). Evidence that a 
central domain of nucleocapsid protein is required for RNA packaging in murine leukemia 
virus. Journal of virology 68, 6124-6129. 
Rein, A., McClure, M.R., Rice, N.R., Luftig, R.B., and Schultz, A.M. (1986). 
Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine 
leukemia virus. Proceedings of the National Academy of Sciences of the United States of 
America 83, 7246-7250. 
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., 
Zanaria, E., Messali, S., Cainarca, S., et al. (2001). The tripartite motif family identifies 
cell compartments. The EMBO journal 20, 2140-2151. 
Risco, C., Menendez-Arias, L., Copeland, T.D., Pinto da Silva, P., and Oroszlan, S. (1995). 
Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 
cells: nuclear import of nucleocapsid protein and integrase. Journal of cell science 108 ( Pt 
9), 3039-3050. 
Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O. (1993). Integration of murine leukemia 
virus DNA depends on mitosis. The EMBO journal 12, 2099-2108. 
Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., and Banting, G. (2007). Clathrin-
mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine 
motif. Journal of cell science 120, 3850-3858. 
Rosenberg, N., and Jolicoeur, P. (1997). Retroviral Pathogenesis. In Retroviruses, J.M. 
Coffin, S.H. Hughes, and H.E. Varmus, eds. (Cold Spring Harbor (NY)). 
47 
 
Roth, M.J., Schwartzberg, P., Tanese, N., and Goff, S.P. (1990). Analysis of mutations in 
the integration function of Moloney murine leukemia virus: effects on DNA binding and 
cutting. Journal of virology 64, 4709-4717. 
Rowe, H.M., Jakobsson, J., Mesnard, D., Rougemont, J., Reynard, S., Aktas, T., Maillard, 
P.V., Layard-Liesching, H., Verp, S., Marquis, J., et al. (2010). KAP1 controls 
endogenous retroviruses in embryonic stem cells. Nature 463, 237-240. 
Rowe, H.M., and Trono, D. (2011). Dynamic control of endogenous retroviruses during 
development. Virology 411, 273-287. 
Rowling, P.J., McLaughlin, S.H., Pollock, G.S., and Freedman, R.B. (1994). A single 
purification procedure for the major resident proteins of the ER lumen: endoplasmin, BiP, 
calreticulin and protein disulfide isomerase. Protein expression and purification 5, 331-336. 
Sabo, Y., Laham-Karam, N., and Bacharach, E. (2008). Basal budding and replication of 
the murine leukemia virus are independent of the gag L domains. Journal of virology 82, 
9770-9775. 
Sakai, H., Shibata, R., Sakuragi, J., Sakuragi, S., Kawamura, M., and Adachi, A. (1993). 
Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for 
maturation of virus particles. Journal of virology 67, 1663-1666. 
Santangelo, A.M., de Souza, F.S., Franchini, L.F., Bumaschny, V.F., Low, M.J., and 
Rubinstein, M. (2007). Ancient exaptation of a CORE-SINE retroposon into a highly 
conserved mammalian neuronal enhancer of the proopiomelanocortin gene. PLoS genetics 
3, 1813-1826. 
Sawyer, S.L., Wu, L.I., Emerman, M., and Malik, H.S. (2005). Positive selection of 
primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. 
Proceedings of the National Academy of Sciences of the United States of America 102, 
2832-2837. 
Schaller, T., Hue, S., and Towers, G.J. (2007). An active TRIM5 protein in rabbits 
indicates a common antiviral ancestor for mammalian TRIM5 proteins. Journal of 
virology 81, 11713-11721. 
48 
 
Schlesinger, S., and Goff, S.P. (2015). Retroviral Transcriptional Regulation and 
Embryonic Stem Cells: War and Peace. Molecular and cellular biology 35, 770-777. 
Schwartzberg, P., Colicelli, J., Gordon, M.L., and Goff, S.P. (1984). Mutations in the gag 
gene of Moloney murine leukemia virus: effects on production of virions and reverse 
transcriptase. Journal of virology 49, 918-924. 
Sebastian, S., and Luban, J. (2005). TRIM5alpha selectively binds a restriction-sensitive 
retroviral capsid. Retrovirology 2, 40. 
Selig, L., Pages, J.C., Tanchou, V., Preveral, S., Berlioz-Torrent, C., Liu, L.X., Erdtmann, 
L., Darlix, J., Benarous, R., and Benichou, S. (1999). Interaction with the p6 domain of the 
gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate 
lentiviruses. Journal of virology 73, 592-600. 
Shackleford, G.M., and Varmus, H.E. (1988). Construction of a clonable, infectious, and 
tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. 
Proceedings of the National Academy of Sciences of the United States of America 85, 
9655-9659. 
Sharma, S., Miyanohara, A., and Friedmann, T. (2000). Separable mechanisms of 
attachment and cell uptake during retrovirus infection. Journal of virology 74, 10790-
10795. 
Sheehy, A.M., Gaddis, N.C., Choi, J.D., and Malim, M.H. (2002). Isolation of a human 
gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 
646-650. 
Sherer, N.M., Lehmann, M.J., Jimenez-Soto, L.F., Ingmundson, A., Horner, S.M., 
Cicchetti, G., Allen, P.G., Pypaert, M., Cunningham, J.M., and Mothes, W. (2003). 
Visualization of retroviral replication in living cells reveals budding into multivesicular 
bodies. Traffic 4, 785-801. 
Shi, X., Seluanov, A., and Gorbunova, V. (2007). Cell divisions are required for L1 
retrotransposition. Molecular and cellular biology 27, 1264-1270. 
49 
 
Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K., and Adachi, A. (1995). Early 
replication block of human immunodeficiency virus type 1 in monkey cells. The Journal 
of general virology 76 ( Pt 11), 2723-2730. 
Shinnick, T.M., Lerner, R.A., and Sutcliffe, J.G. (1981). Nucleotide sequence of Moloney 
murine leukaemia virus. Nature 293, 543-548. 
Shoeman, R.L., Sachse, C., Honer, B., Mothes, E., Kaufmann, M., and Traub, P. (1993). 
Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human 
immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. The 
American journal of pathology 142, 221-230. 
Simon, J.H., Gaddis, N.C., Fouchier, R.A., and Malim, M.H. (1998). Evidence for a newly 
discovered cellular anti-HIV-1 phenotype. Nature medicine 4, 1397-1400. 
Singer, M.F. (1982). SINEs and LINEs: highly repeated short and long interspersed 
sequences in mammalian genomes. Cell 28, 433-434. 
Singer, T., McConnell, M.J., Marchetto, M.C., Coufal, N.G., and Gage, F.H. (2010). 
LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends in 
neurosciences 33, 345-354. 
Slotkin, R.K., and Martienssen, R. (2007). Transposable elements and the epigenetic 
regulation of the genome. Nature reviews Genetics 8, 272-285. 
Sohn, W.J., Kim, D., Lee, K.W., Kim, M.S., Kwon, S., Lee, Y., Kim, D.S., and Kwon, H.J. 
(2007). Novel transcriptional regulation of the schlafen-2 gene in macrophages in response 
to TLR-triggered stimulation. Molecular immunology 44, 3273-3282. 
Song, B., Javanbakht, H., Perron, M., Park, D.H., Stremlau, M., and Sodroski, J. (2005). 
Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. 
Journal of virology 79, 3930-3937. 
50 
 
Sova, P., and Volsky, D.J. (1993). Efficiency of viral DNA synthesis during infection of 
permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 
1. Journal of virology 67, 6322-6326. 
Spence, S.E., Gilbert, D.J., Swing, D.A., Copeland, N.G., and Jenkins, N.A. (1989). 
Spontaneous germ line virus infection and retroviral insertional mutagenesis in eighteen 
transgenic Srev lines of mice. Molecular and cellular biology 9, 177-184. 
Stevenson, M. (2003). HIV-1 pathogenesis. Nature medicine 9, 853-860. 
Stocking, C., and Kozak, C.A. (2008). Murine endogenous retroviruses. Cellular and 
molecular life sciences : CMLS 65, 3383-3398. 
Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., and Martin, M.A. (1987). The 
HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730. 
Stremlau, M., Owens, C.M., Perron, M.J., Kiessling, M., Autissier, P., and Sodroski, J. 
(2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old 
World monkeys. Nature 427, 848-853. 
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., 
Anderson, D.J., Sundquist, W.I., and Sodroski, J. (2006). Specific recognition and 
accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. 
Proceedings of the National Academy of Sciences of the United States of America 103, 
5514-5519. 
Stremlau, M., Perron, M., Welikala, S., and Sodroski, J. (2005). Species-specific variation 
in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human 
immunodeficiency virus restriction. Journal of virology 79, 3139-3145. 
Swanstrom, R., and Wills, J.W. (1997). Synthesis, Assembly, and Processing of Viral 




Tanese, N., and Goff, S.P. (1988). Domain structure of the Moloney murine leukemia 
virus reverse transcriptase: mutational analysis and separate expression of the DNA 
polymerase and RNase H activities. Proceedings of the National Academy of Sciences of 
the United States of America 85, 1777-1781. 
Taruscio, D., and Mantovani, A. (2004). Factors regulating endogenous retroviral 
sequences in human and mouse. Cytogenetic and genome research 105, 351-362. 
Teich, N.M., Weiss, R.A., Martin, G.R., and Lowy, D.R. (1977). Virus infection of murine 
teratocarcinoma stem cell lines. Cell 12, 973-982. 
Telesnitsky, A., and Goff, S.P. (1997). Reverse Transcriptase and the Generation of 
Retroviral DNA. In Retroviruses, J.M. Coffin, S.H. Hughes, and H.E. Varmus, eds. (Cold 
Spring Harbor (NY)). 
Toh, H., Kikuno, R., Hayashida, H., Miyata, T., Kugimiya, W., Inouye, S., Yuki, S., and 
Saigo, K. (1985). Close structural resemblance between putative polymerase of a 
Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine 
leukaemia virus. The EMBO journal 4, 1267-1272. 
Trelogan, S.A., and Martin, S.L. (1995). Tightly regulated, developmentally specific 
expression of the first open reading frame from LINE-1 during mouse embryogenesis. 
Proceedings of the National Academy of Sciences of the United States of America 92, 
1520-1524. 
Tucker, S.P., Srinivas, R.V., and Compans, R.W. (1991). Molecular domains involved in 
oligomerization of the Friend murine leukemia virus envelope glycoprotein. Virology 185, 
710-720. 
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R.L., Mitchell, R., Johnson, M.C., 
Stephens, E.B., and Guatelli, J. (2008). The interferon-induced protein BST-2 restricts 
HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell 
host & microbe 3, 245-252. 
van Zeijl, M., Johann, S.V., Closs, E., Cunningham, J., Eddy, R., Shows, T.B., and O'Hara, 
B. (1994). A human amphotropic retrovirus receptor is a second member of the gibbon ape 
52 
 
leukemia virus receptor family. Proceedings of the National Academy of Sciences of the 
United States of America 91, 1168-1172. 
Varmus, H.E., Padgett, T., Heasley, S., Simon, G., and Bishop, J.M. (1977). Cellular 
functions are required for the synthesis and integration of avian sarcoma virus-specific 
DNA. Cell 11, 307-319. 
Varthakavi, V., Smith, R.M., Bour, S.P., Strebel, K., and Spearman, P. (2003). Viral 
protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. 
Proceedings of the National Academy of Sciences of the United States of America 100, 
15154-15159. 
Vogt, V.M. (1996). Proteolytic processing and particle maturation. Current topics in 
microbiology and immunology 214, 95-131. 
Vogt, V.M. (1997). Retroviral Virions and Genomes. In Retroviruses, J.M. Coffin, S.H. 
Hughes, and H.E. Varmus, eds. (Cold Spring Harbor (NY)). 
Wang, G.Z., Wolf, D., and Goff, S.P. (2014a). EBP1, a novel host factor involved in 
primer binding site-dependent restriction of moloney murine leukemia virus in embryonic 
cells. Journal of virology 88, 1825-1829. 
Wang, H., Kavanaugh, M.P., North, R.A., and Kabat, D. (1991). Cell-surface receptor for 
ecotropic murine retroviruses is a basic amino-acid transporter. Nature 352, 729-731. 
Wang, J., Xie, G., Singh, M., Ghanbarian, A.T., Rasko, T., Szvetnik, A., Cai, H., Besser, 
D., Prigione, A., Fuchs, N.V., et al. (2014b). Primate-specific endogenous retrovirus-
driven transcription defines naive-like stem cells. Nature 516, 405-409. 
Wicker, T., Sabot, F., Hua-Van, A., Bennetzen, J.L., Capy, P., Chalhoub, B., Flavell, A., 
Leroy, P., Morgante, M., Panaud, O., et al. (2007). A unified classification system for 
eukaryotic transposable elements. Nature reviews Genetics 8, 973-982. 
53 
 
Wolf, D., Cammas, F., Losson, R., and Goff, S.P. (2008). Primer binding site-dependent 
restriction of murine leukemia virus requires HP1 binding by TRIM28. Journal of virology 
82, 4675-4679. 
Wolf, D., and Goff, S.P. (2007). TRIM28 mediates primer binding site-targeted silencing 
of murine leukemia virus in embryonic cells. Cell 131, 46-57. 
Wolf, D., and Goff, S.P. (2008). Host restriction factors blocking retroviral replication. 
Annual review of genetics 42, 143-163. 
Wolf, D., and Goff, S.P. (2009). Embryonic stem cells use ZFP809 to silence retroviral 
DNAs. Nature 458, 1201-1204. 
Wu, X., Anderson, J.L., Campbell, E.M., Joseph, A.M., and Hope, T.J. (2006). 
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse 
transcription and infection. Proceedings of the National Academy of Sciences of the 
United States of America 103, 7465-7470. 
Xu, L., Yang, L., Moitra, P.K., Hashimoto, K., Rallabhandi, P., Kaul, S., Meroni, G., 
Jensen, J.P., Weissman, A.M., and D'Arpa, P. (2003). BTBD1 and BTBD2 colocalize to 
cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Experimental cell 
research 288, 84-93. 
Yap, M.W., Nisole, S., Lynch, C., and Stoye, J.P. (2004). Trim5alpha protein restricts both 
HIV-1 and murine leukemia virus. Proceedings of the National Academy of Sciences of 
the United States of America 101, 10786-10791. 
Yoshimoto, T., Yoshimoto, E., and Meruelo, D. (1993). Identification of amino acid 
residues critical for infection with ecotropic murine leukemia retrovirus. Journal of 
virology 67, 1310-1314. 
Yoshinaka, Y., Katoh, I., Copeland, T.D., and Oroszlan, S. (1985). Murine leukemia virus 
protease is encoded by the gag-pol gene and is synthesized through suppression of an 
amber termination codon. Proceedings of the National Academy of Sciences of the United 
States of America 82, 1618-1622. 
54 
 
Yuan, B., Campbell, S., Bacharach, E., Rein, A., and Goff, S.P. (2000). Infectivity of 
Moloney murine leukemia virus defective in late assembly events is restored by late 
assembly domains of other retroviruses. Journal of virology 74, 7250-7260. 
Yuan, B., Li, X., and Goff, S.P. (1999). Mutations altering the moloney murine leukemia 
virus p12 Gag protein affect virion production and early events of the virus life cycle. The 
EMBO journal 18, 4700-4710. 
Yueh, A., and Goff, S.P. (2003). Phosphorylated serine residues and an arginine-rich 
domain of the moloney murine leukemia virus p12 protein are required for early events of 
viral infection. Journal of virology 77, 1820-1829. 
Zhang, H., Dornadula, G., Orenstein, J., and Pomerantz, R.J. (2000). Morphologic changes 
in human immunodeficiency virus type 1 virions secondary to intravirion reverse 
transcription: evidence indicating that reverse transcription may not take place within the 
intact viral core. Journal of human virology 3, 165-172. 
Zhang, H., Yang, B., Pomerantz, R.J., Zhang, C., Arunachalam, S.C., and Gao, L. (2003). 
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. 
Nature 424, 94-98. 
Zhang, W.H., Hockley, D.J., Nermut, M.V., Morikawa, Y., and Jones, I.M. (1996). Gag-
Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 
capsid antigen are essential for Gag particle assembly. The Journal of general virology 77 
( Pt 4), 743-751. 
Zhang, Y., Burke, C.W., Ryman, K.D., and Klimstra, W.B. (2007). Identification and 
characterization of interferon-induced proteins that inhibit alphavirus replication. Journal 
of virology 81, 11246-11255. 
Zhu, Y., Wang, X., Goff, S.P., and Gao, G. (2012). Translational repression precedes and 


















          The replication of Moloney Murine Leukemia Virus (MLV) is strongly suppressed in 
mouse embryonic stem cells (ES) and carcinoma cells (EC) but not in differentiated cells. 
Proviral DNAs are specifically silenced in embryonic cells by a large complex containing 
Trim28 (also known as KAP-1), HP1 (heterochromatin protein 1), and chromatin modifying 
enzymes that repress transcription of the viral DNA. This silencing complex is targeted to a 
short DNA sequence element, which overlaps with Primer Binding Site (PBS) of MLV, by 
the DNA sequence-specific zinc finger protein ZFP809, which is specifically expressed in 
embryonic cells. The ectopic expression of ZFP809 in differentiated cells is sufficient to 
induce silencing, suggesting that ZFP809 is the key embryonic-specific component of the 
silencing machinery. To determine the mechanism of regulation of ZFP809, we examined the 
levels of ZFP809 mRNA and protein. Though the levels of ZFP809 mRNA were similar in 
embryonic and differentiated cells, ZFP809 protein was found to be stable in embryonic cells 
and highly unstable in differentiated cells. The protein was stabilized by the proteasome 
inhibitor MG132 and accumulated heavy modification by addition of polyubiquitin chains. A 
short sequence of amino acids at the C-terminus of ZFP809, including a single lysine residue, 
was required and sufficient to mediate the rapid turnover of the protein. Depletion of Trim28 
stabilizes ZFP809 in differentiated cells. Abolishing the interaction between Trim28 and 
ZFP809 by introducing mutation in ZFP809 also stabilizes the protein, which indicating that 
Trim28 promotes the degradation of ZFP809 in differentiated cells. The neddylation inhibitor 




          Replication of murine leukemia viruses is blocked in murine embryonic stem (ES) cells 
and other primitive stem cells (Teich et al., 1977; Wolf and Goff, 2007). Infection results in 
normal entry, reverse transcription and integration of proviral DNA, but the DNA is then 
silenced transcriptionally. A specific DNA sequence utilized to prime viral DNA synthesis, 
the Primer Binding Site complementary to the proline tRNA (PBSpro), is present on those 
viruses that are most strongly and rapidly silenced. A large protein complex is specifically 
expressed in ES cells and binds to the PBS sequences to mediate the transcriptional 
repression of proviral DNA (Barklis et al., 1986; Petersen et al., 1991; Wolf and Goff, 2008; 
Yamauchi et al., 1995). Work from our lab and others have shown that this silencing complex 
contains the transcriptional repressor Trim28, also known as KAP-1 or TIF1b. The complex 
is tethered to viral DNA by ZFP809, a zinc finger protein with sequence-specific DNA 
binding activity (Wolf et al., 2008; Wolf and Goff, 2007, 2009).  ZFP809 binds directly to the 
PBSpro of proviral DNA, initiating the silencing (Wolf and Goff, 2009).  
          Trim28 contains several conserved domains, including a RBCC (Ring finger, two B-
box zinc fingers, and a coiled coil) domain, a central TIF1 signature sequence (TSS) domain 
and a C-terminal combination plant homeodomain (PHD) and bromo domain (Friedman et al., 
1996; Iyengar and Farnham, 2011). The RBCC domain binds as a homotrimer to a KRAB 
domain and encapsulates it to a protease resistant core (Peng et al., 2007). After tethering to a 
specific DNA region by KRAB-ZNFs, Trim28 recruits a number of other factors including 
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the NuRD histone deacetylase complex, the histone H3K9 methyltransferase ESET, and HP1 
to silence the specific DNA area (Le Douarin et al., 1996; Schultz et al., 2002; Schultz et al., 
2001). Trim28 also plays an important role in the protein modification pathway. The Ring 
domain containing proteins is a large family of E3 ligases (Deshaies and Joazeiro, 2009; 
Saurin et al., 1996). MAGE-C2-Trim28 was shown to target p53 for proteasome-dependent 
degradation (Doyle et al., 2010). The PHD domain of Trim28 functions as an intracellular E3 
ligase that sumolyates adjacent Bromo domain which is essential for the interaction between 
Trim28 and ESET methyltransferase (Ivanov et al., 2007; Zeng et al., 2008).  
          ZFP809 contains two domains, a KRAB box in the N-terminal which is responsible for 
the interaction with Trim28 and a zinc finger domain containing seven zinc fingers and 
having the DNA binding activity (Figure 1A). While most of the components of the silencing 
complex are expressed ubiquitously, ZFP809 is expressed specifically in ES cells and not in 
differentiated cells. Ectopic expression of ZFP809 alone in differentiated cells is sufficient to 
establish the silencing in those cells (Wolf and Goff, 2009), suggesting that the lack of 
restriction of MLV in differentiated cells is largely due to the reduced amount of ZFP809 
protein. The basis of the cell-type specific expression of ZFP809 is not known. ES cells have 
unusual transcriptional profiles, and a natural supposition would be that the ZFP809 gene is 
specifically transcribed in ES cells. But the cell-type expression of proteins such as ZFP809 
could be effected by regulation at any of several steps: at the level of transcription(Sproul et 
al., 2005), post-transcriptional mRNA processing or stability, mRNA translation (Chen and 
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Rajewsky, 2007), or post-translational protein modification or stability (Haas et al., 1982). To 
test this idea, we have directly examined the synthesis and stability of the ZFP809 protein. 
We find that the down regulation of ZFP09 in differentiated cells is not due to the reduction 
of ZFP809 mRNA but to changes in protein stability. The full-length ZFP809 protein is 
relatively stable in ES cells but is degraded rapidly in differentiated cells. Mutagenesis 
analysis and protein ubiquitination assays indicate that the degradation is mediated through 
the ubiquitin-dependent proteosomal pathway. A lysine residue in the C-terminal domain is 
essential for the turnover of ZFP809. Depletion of Trim28 or abolishing the interaction 
between Trim28 and ZFP809 also stabilizes ZFP809 in differentiated cells, which indicates 
that Trim28 promotes the degradation of ZFP809 in those cells. 
2.3 Methods 
2.3.1 Cell culture and transfection 
        293A cells are human embryonic kidney cells. 293T cells are human embryonic kidney 
cells that stably express simian virus 40 (SV40) large T-Antigen. NIH3T3 cells are mouse 
embryonic fibroblast cells. Rat2 cells are rat fibroblast cells.  293A, 293T, NIH3T3 and Rat2 
cell lines were maintained in Dulbecco’s modified Eagle medium supplemented with 10% 
fetal bovine serum, 100 UI/ml penicillin and 100mg/ml streptomycin. Mouse ES cells, E14, 
were cultured on the MEF layer in the medium of DMEM with 20% defined FBS, 
nonessential amino acids, 2uM sodium pyruvate, 100 UI/ml penicillin, 100 mg/ml 
streptomycin and 1000 units of LIF (Stem Cell Technologies). E14 cells were transferred to 
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plates coated with 0.1% gelatin for transfection purpose. DNAs were transfected into cells 
using polyethylenimine reagent (Akinc et al., 2005) or Lipofectamine 2000 according to the 
manufacturer’s instruction. All cells were cultured at 37°C in 5% CO2. 
2.3.2 Plasmids 
          The plasmids of pcDNA3.1 3X Flag ZFP809(FL) or ZFP809(1-353) were described 
before (Wolf and Goff, 2009). Fragments with 3X Flag ZFP809(FL) or ZFP809(1-353) were 
swiped to pLVX IRES mCherry vector using the SnaBI and XhoI sites. 3X Flag ZFP809(FL) 
were cloned into pLVX EF1α IRES puro vector using the EcoRI and BamHI restriction sites. 
Renilla luciferase gene was cloned into pcDNA3.1 3XFlag vector using BamHI and HindIII 
restriction site. The 5’UTR, cDNA sequence and 3’UTR of ZFP809 mRNA were inserted 
between HindIII and NotI after the stop codon of the Renilla luciferase gene in pcDNA3.1 
Renilla luciferase vector. Plasmids of pcDNA3 Flag p53 and pCI-his-Ubiquitin were 
purchased from Addgene. Mutations of ZFP809 were introduced using overlap extension 
PCR (Higuchi et al., 1988) and SLIC cloning (Li and Elledge, 2012), which replaced the last 
lysine residue (K391A) of ZFP809 to alanine or residues(D8V9 to AA). The C terminus of 
ZFP809 was cloned into pEGFP C1 vector using EcoRI and BamHI restriction site to 
generate pEGFP ZFP809 C50.  While cloning of pcDNA3.1 3XFlag Renilla luciferase, a SalI 
right before the stop codon of Renilla luciferase gene for inducing ZFP809 C50 in the C 




Oligonucleotides for cloning pcDNA3.1 3XFlag Renilla luciferase 
Forward primer   CATCATCACCATCACCATaccggtATG ACTTCGAAAGTTTATGATC 
Reverse primer 
TTCCAGTCTTTGAAATCTCAaccggtTTAGTCGACTTGTTCATTTTTGAGAACTCGC 
Oligonucleotides for cloning pcDNA3.1 3XFlag Renilla luciferase ZFP809 5UTR, CDS or 
3UTR 
5UTR forward primer   atgc AAGCTT GGGGTGGATTTAGAAAGTTCAGA 
5UTR reverse primer    agct GCGGCCGC ATGATGGGACTGGGAGCGTC 
CDS forward primer     atgc AAGCTT CATGGGGTTGGTGTCCTTT 
CDS reverse primer      agct GCGGCCGC TCAGAGCCCACCCCCAAT 
3UTR forward primer   atgc AAGCTT TGGGCTCTGAGATTTCAAAGAC 
3UTR reverse primer    agct GCGGCCGC TTTTTTTTTTTTTTTTTTTTTTTTTTTT 
Oligonucleotides for cloning pcDNA3.1 3XFlag ZFP809(DV to AA) 
Forward primer (restriction site Nhe1)       AGGGAGACCCAAGCTGGCTA 
DVR      CACGGCTGCAGCCTCAAAGGA 
DVF      TCCTTTGAGGCTGCAGCCGTG 
Reverse primer (restriction site Xho1)        AACGGGCCCTCTAGACTCGA 
Oligonucleotides for cloning pcDNA3.1 3X Flag ZFP809(K391A) 
Forward primer (restriction site BamH1)        TTGGTACCGAGCTCGGATC  
K391AR      ATGGCATTATGGACTTTGTGGCAGCGTGGAGCAGGTGTATCAT  
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K391AF      ATGATACACCTGCTCCACGCTGCCACAAAGTCCATAATGCCAT  
Reverse primer (restriction site Xho1)         AACGGGCCCTCTAGACTCGA 
Oligonucleotides for generating pEGFP ZFP809 C50 
Forward primer    tagc GAATTC CAAGAGGTAGTTTTCCAACAGATCA 
Reverse primer    tcga GGATCC TCAGAGCCCACCCCCAATGATA 
2.3.3 Digital analysis of ZFP809 mRNA levels 
          The RNA expression data of ZFP809 was obtained from the RNA expression data 
published by Meissner Group (Mikkelsen et al., 2008) and the online database BioGPS. The 
cell lines, B cell, MEF (mouse embryonic fibroblast),  and ES (embryonic stem) were 
generated from ROSA26–M2rtTA mice (Beard et al., 2006). IPS (induced pluripotent stem) 
cells were induced from MEFs. Expression data were generated from polyA RNA using 
GeneChip Mouse Genome 430 2.0 Arrays (Affymetrix). Absolute values were normalized by 
Robust Multi-Array (RMA) and processed using Genepattern 
(http://www.broad.mit.edu/cancer/software/genepattern/) (Mikkelsen et al., 2008). ZFP809 
expression data in mouse tissues of NK, T-cell CD4+, T-cell CD8+, bone marrow and ES 
cells were selected in BioGPS database.  
2.3.4 Analysis of ZFP809 mRNA level by quantitative PCR 
       Total RNA of E14, F9 and NIH3T3 cells was extracted using TRIZOL reagent 
(Invitrogen). 4 μg of total RNA per cell line were used to produce cDNA using random 
hexamers and SuperScript III kit (Invitrogen). 2 μl of each cDNA were used for quantitative 
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PCR analysis of ZFP809 and GAPDH mRNA levels. The expression of ZFP809 was 
normalized to the level of GAPDH.  
2.3.5 Colony formation assay 
          NIH3T3 cells were transfected with pcDNA3.1 3X Flag, pcDNA3.1 3C Flag 
ZFP809(FL) or ZFP809(1-353). 48 hours after transfection, cells were selected in G418 
(1ug/ml) and counted after 14 days of selection. 
2.3.6 Protein degradation assay 
          All reagents were purchased from Sigma and dissolved in DMSO.  24 hours after 
transfecting plasmids into 293T, 293A or E14 (mouse ES) cells, 50μg/ml of cycloheximide 
(CHX) was added to stop translation (Schneider-Poetsch, Ju et al. 2010). Cells were lysed by 
addition of Laemmli buffer at different time points after drugs were added: 0, 10min, 30min, 
1h, 2h, 3h and subjected to immunoblotting with anti-Flag antibody for measuring the 
amount of ZFP809 proteins. ES cells were treated with Trichostatin A (TSA, 500nM) and 
Forskolin (FSK, 0.1mM) for 4 hours before addition of CHX. Drugs of MG132 (30μM), 
Chloroquine (100μM), MLN4924 (1mM) were added with CHX for indicated purposed. 
2.3.7 In vivo ubiquitination assay 
          293T cells were transfected with DNAs expressing ZFP809(FL) only or both 
ZFP809(FL) and his-tagged ubiquitin. 24 hours after transfection, MG132 was added to stop 
protein degradation for 4 hours. Cells were lysed in buffer A (6 M guanidinium-HCl, 0.1 M 
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Na2HPO4/NaH2PO4, 0.01 M Tris–HCl pH 8.0, 5 mM imidazole, 10 mM β-mercaptoethanol) 
and the cell lysates were incubated with Ni
2+
-NTA beads (Qiagen) for 4 h at room 
temperature. The beads were washed with buffer A, B (8 M urea, 0.1 M Na2PO4/NaH2PO4, 
0.01 M Tris–HCl pH 8.0, 10 mM β-mercaptoethanol), C (8 M urea, 0.1 M Na2PO4/NaH2PO4, 
0.01 M Tris–HCl pH 6.3, 10 mM β-mercaptoethanol), and bound proteins were eluted with 
Laemmli buffer (modified from (Wang et al., 2005)). Samples were analyzed by western 
blotting with anti-Flag antibody (Sigma). 
2.3.8 Western blotting 
          The proteins were resolved by SDS-polyacrylamide gel electrophoresis (PAGE). After 
transfer to nitrocellulose membranes, the blots were probed with mouse anti Flag monoclonal 
antibody (Sigma), mouse anti mCherry monoclonal antibody (abcam), mouse anti TRIM28 
monoclonal antibody (abcam), mouse anti Tubulin monoclonal antibody (abcam) or mouse 
anti beta-actin monoclonal antibody.  Secondary antibody was ECL anti mouse IgG, 
horseradish peroxidase linked whole antiboday (GE healthcare). Membranes were developed 
using ECL reagents (Life Technologies).  
2.3.9 Luciferase assay 
          293T cells seeded in a 6-well plate were transfected with empty vector, Renilla 
luciferase, and Renilla luciferase with ZFP809 mRNA elements. Transfection was carried out 
using polyethylenimine (PEI) protocol in which the constructs were added at a 3 (Renilla 
luciferase) : 1 (firefly luciferase, transfection efficiency control) ratio. Cells were lysed 48-
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hours post transfection with Passive lysis buffer (Promega) and the luciferase activity was 
measured using a Dual-Glo luciferase assay system (Promega) in a Veritas Microplate 
luminometer. Renilla luciferase data were normalized to Firefly luciferase readings in each 
well.  
2.3.10 Knockdown of TRIM28  
          For the transient knockdown of Trim28, 293A cells were transfected with siRNA 
specifically targeting Trim28 or a non-targeting siRNA (Thermo Scientific). Cells were 
transfected with Lipofectamine2000 (Invitrogen) using a 2-day transfection protocol followed 
by 24-hours or 48-hours of rest to gain maximum knockdown efficiency. Cells were collected 
following the resting period and analyzed by western blotting. 
2.3.11 Protein interaction assay 
        Same amount plasmids of pcDNA3 3X Flag, pcDNA3 3Xflag ZFP809(FL) or pcDNA3 
3X Flag ZFP809(DV-AA) were transfected into 293T cells. 24 hours after transfection, cells 
were lysed in IPH buffer. Cell lysates were incubated with anti-Flag magnetic beads (sigma). 
After 4 hours of incubation, beads were washed with modified IPH buffer (the concentration 
of detergent was increased to 1%) and eluted with Laemmli buffer. The elution was probed 




2.4.1 Expression of mRNAs and proteins of ZFP809 in different cells types 
          The transcriptional silencing complex binding to the PBSpro of the murine leukemia 
viruses is only present in nuclear extracts of ES and other primitive cell types, and not in 
differentiated cells. The key ES-cell specific component of this complex is ZFP809. 
Expression of ZFP809 alone in differentiated cells are sufficient to re-establish the restriction, 
which indicates that lack of ZFP809 protein in differentiated cells result in the loss of 
restriction. Surprisingly, RNA expression databases indicate that the mRNA levels of 
ZFP809 are roughly comparable among murine ES, IPS and differentiated cells (Figure 8A) 
(Mikkelsen et al., 2008). ZFP809 mRNA levels were not specifically higher in ES cells, but 
sometimes were modestly lower in ES cells than in other tissues (Figure 8B) (Wu et al., 
2009) . 
         To confirm these whole-genome expression data, we directly assessed the ZFP809 
mRNA levels in different cell types by real time PCR. The mRNA levels of ZFP809 in 
mouse ES cells (E14), EC cells (F9) and fibroblast cells (NIH3T3) were all comparable 
(Figure 8C), suggesting that the expression was not controlled by differential transcription, 
nor differential stability of the mRNA.  
          Our initial efforts to establish cell lines stably expressing the full-length ZFP809(FL) 
were not immediately successful (Wolf and Goff, 2009), Transformation of differentiated 
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cells with DNA constructs expressing the full-length ZFP809 cDNA resulted in the isolation 
of cell lines expressing only very low levels of the protein. Screening large numbers of 
colonies arising after transformation yielded a few that expressed high levels, but these lines 
were found to express a truncated form. Then we cloned a short-form of the gene, ZFP809(1-
353), lacking the C-terminal 50 amino acids and retaining the Zinc fingers and Krab box 
(Wolf and Goff, 2009). Ecotopic expression of ZFP809(1-353) in vectors carrying neomycin 
resistance gene resulted in much more colonies than that of ZFP809(FL) after G418 selection 
(Figure 9). Overall, the observations suggest that full-length ZFP809 may be toxic to 
differentiated cells. 
          To confirm these observations, we transformed 293T cells with the same amount of 
DNAs encoding epitope flag-tagged versions of the full-length cDNA (ZFP809(FL)) or the 
truncated form (ZFP809(1-353)), and examined the levels of expressed protein by Western 
blotting (Figure 10A). The levels of the full-length protein were significantly lower than that 
of the truncated form (Figure 10A). To rule out the possibility that the difference in 
expression was due to inconsistency of transfection efficiency or mRNA stability, both forms 
of ZFP809 cDNA were cloned into a vector expressing a single bicistronic mRNA encoding 
both ZFP809 and an mCherry reporter translated from an IRES element. 293T or NIH3T3 
cells were transformed with the DNAs, and the levels of the expressed proteins were assessed 
by Western blotting. The full-length ZFP809 was expressed at much lower levels than 
ZFP809 (1-353), while the levels of mCherry protein were approximately the same in both 
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293T and NIH3T3 cells (Figure 10B). These results suggest that full-length ZFP809 protein 
is significant down-regulated by translational or post-translational mechanisms.  
2.4.2 Rapid degradation of full-length ZFP809 protein in differentiated cells 
          Introducing a heterologous posttransciptional or translational regulator in the form of 
an RNA element to the mRNA of a reporter gene could establish the corresponding 
regulation of the reporter gene (Ha et al., 1996). To test whether sequences of ZFP809 
mRNA would regulate the expression of other genes, we sub-cloned the 5’UTR, 3’UTR and 
cDNA sequences of ZFP809 mRNA and a scrambled sequence after the stop codon of 
Renilla luciferase reporter gene to make vectors Rluc, Rluc-5UTR, Rluc-CDS, Rluc-3UTR 
and Rluc-scram (Figure 11A). 48 hours after transfecting same amount of those vectors with 
a Firefly luciferase vector as a control into 293T cells, the luciferase units were measured by 
the Promega dual-luciferase reporter assay system. Renilla luciferase units were normalized 
to firefly luciferase units to generate relative Renilla luciferase unit (RLU). RLU of different 
DNAs was approximately the same, which suggested that neither post-transcriptional RNA 
regulation nor translation were likely points of regulation (Figure 11B).  
          To test if the low levels of full-length ZFP809 protein in differentiated cells were due 
to protein degradation, protein degradation assays were performed. Flag-tagged ZFP809(FL) 
and ZFP809(1-353) were expressed by transfection into 293T cells and 24 hours after 
transfection, cycloheximide (CHX) was added to block translation (Schneider-Poetsch et al., 
2010). Cells were lysed at various times after addition of CHX (0, 10min, 30min, 1 hour, 2 
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hours and 3hours). Then the levels of ZFP809 were assessed using Western blotting. The 
blotting showed that levels of full-length ZFP809 protein dropped rapidly upon inhibition of 
translation, while the levels of ZFP809(1-353) remained relatively constant in those cells 
(Figure 12A). In order to calculate the half-life of ZFP809(FL), the intensity of each band 
was figured out by ImageJ. Exponential regression of the band intensity showed that the half-
life of ZFP809 full-length protein was about 45min (Figure 12B).  
          Due to the low transfection efficiency of mouse ES cells and rapid silencing of CMV 
promoter in ES cells (Chung et al., 2002), the expression of ZFP809 driven by CMV 
promoter was undetectable after transfection. As a result, two drugs, Trichostatin A (TSA) 
(Spenger et al., 2004) and forskolin (FSK) (Keller et al., 2007) were added to release the 
restriction of CMV promoter in mouse ES cells when performing protein degradation assays 
in ES cells. TSA is a fungal antibiotic selective inhibiting mammalian histone deacetylase 
enzymes which act as transcription repressors (Vanhaecke et al., 2004). FSK activates the 
enzyme adenylyl cyclase and increases intracellular levels of cAMP, which stimulates the 
expression of promoter enhancer CREB (Wilkinson and Akrigg, 1992).  EF1 promoter was 
shown to work efficiently in ES cells and hence was used to drive the expression of ZFP809 
(Hong et al., 2007). The protein degradation assay showed that full-length ZFP809 proteins 
are stable in E14 ES cells (Figure 13). Since expression of ZFP809 in differentiated cells 
alone could restore the restriction, loss of silencing of MLV in differentiated cells might be 
due to the low abundance of ZFP809 protein, which is rapidly degraded in those cells. 
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          Attaching small unstable peptides to proteins may induce the turnover and degradation 
of tagged proteins (Li et al., 1998). We showed that the short peptide in the C terminal is 
essential for the turnover of ZFP809. To test if this peptide can destabilize other proteins, we 
tagged the peptide of ZFP809 C terminus (ZFP809 C50) to the C terminal of EGFP and 
Renilla luciferase. Protein degradation assay showed that ZFP809 C50 tagged-GFP is stable 
in differentiated cells and luciferase units of Renilla C50 did not reduce much after addition 
of CHX. Those observations showed that the peptide alone is not sufficient to drive the 
turnover of those proteins (Figure 14A and B).  
2.4.3 Proteasomal degradation of ZFP809  
           The intracellular degradation of proteins might be achieved in two major cellular 
pathways, lysosome and proteasome (Peters et al., 1994; Settembre et al., 2013).  Lysosome 
is capable of breaking down all kinds of biomolecules, including proteins, nucleic acids and 
cell debris. Lysosomes are important organelles of protein degradation, particularly under 
stress conditions and most of the proteolysis of cytosolic proteins that occurs in lysosomes is 
relatively nonspecific (Knop et al., 1993). A lysosomotropic agent, chloroquine (CQ), can 
accumulate inside the lysosome and inhibit lysosomal protein degradation (Shintani and 
Klionsky, 2004). The main function of proteasomes is to selectively turn over and degrade 
unwanted or damaged proteins through proteolysis (Etlinger and Goldberg, 1977; 
Hochstrasser, 1996). Proteasomes count for the 80% of protein degradation in cells. The 26S 
proteasomes contain one 20S core subunit and two 19S regulatory cap subunits (Peters et al., 
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1994). MG132 is a potent, membrane-permeable proteasome inhibitor (Rock et al., 1994). To 
find out through which pathway ZFP809 is degraded, MG132, CQ or DMSO was added with 
CHX to test if they are capable of stabilizing ZFP809 in differentiated cells. Immunoblotting 
of samples collected at different time points after adding drug showed that MG132 alone, but 
not CQ can stabilize the full-length protein of ZFP809 while block of translation in 
differentiated cells, which indicates that full-length ZFP809 is degraded through the 
proteosomal pathway, not the lysosomal pathway (Figure 15A and B). MG132 also stabilizes 
ZFP809 in a rodent cell line Rat2 (Figure 15C).  
2.4.4 Proteasomal degradation of ZFP809 is ubiquitin-dependent 
           Degradation of proteins by proteasome is in two different manners, ubiquitin-
dependent and ubiquitin-independent (Rape and Jentsch, 2002; Thrower et al., 2000). 
Ubiquitin-dependent pathway, with covalent link of Ubiquitin proteins to a lysine residue of 
the substrate, requires the coordination of three enzymes, the ubiquitin-activating enzyme 
(E1), ubiquitin-conjugating enzyme (E2) and ubiquitin ligase (E3). The ubiquitin ligase 
recognizes the substrate and transfer the ubiquitin from E2 to the substrate. Therefore, E3 
confers the substrate specificity of the proteosomal system (Risseeuw et al., 2003). Proteins 
with intrinsically unstructured regions, might be targeted for ubiquitin-independent 
degradation (Asher et al., 2006). We previously showed that the 50 amino acids in the C-
terminal of ZFP809 are responsible for the instability of ZFP809 (Figure 12A). Deletion of 
the 50 amino acids dramatically stabilizes ZFP809 in differentiated cells (Figure 12A). There 
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is only one lysine residue in this region. To test if the only lysine residue in C terminal of 
ZFP809 is important for the turnover of ZFP809, We mutated the lysine residue to alanine to 
make the construct ZFP809(K391A). Protein degradation assay showed that ZFP809(K391A) 
is stable in differentiated cells (Figure 16A and B), which indicates a role for the lysine 
residue on the turnover of ZFP809.  
          Proteins undergoing ubiquitin-mediated degradation are attached multiple copies of 
ubiquitin, which shows up in the form of a ladder when probed by western blotting(Maki et 
al., 1996). A plasmid expressing His-tagged ubiquitin (Young et al., 2011) was co-transfected 
with vectors expressing flag-tagged ZFP809(FL) or p53 (Yu et al., 1999) into 293T cells. 24 
hours after transfection, MG132 was added to stop degradation for 4 hours. Then cells were 
lysed and the lysates were incubated with Ni-NTA beads (Medina et al., 2000). The bound 
proteins were eluted and subjected to western blotting using anti-Flag antibody. Flag-tagged 
ZFP809 and p53 were detected in lanes added with His-tagged ubiquitin. The precipitated 
ZFP809 and p53 have larger molecular weights than original Flag-tagged ones, which 
demonstrates modification by ubiquitin proteins (Figure 17).  
          In summary, ZFP809 is ubiquitinated in differentiated cells and the lysine residue in 
the C-terminal is essential for the turnover of ZFP809, suggesting that full-length ZFP809 
may be degraded through the ubiquitin-dependent pathway. The ZFP809 mutation, 
ZFP809(K391A) are relatively stable in differentiated cells, suggesting that the lysine residue, 
K391 is important for the turnover of ZFP809. Full length ZFP809 is heavily ubiquitinated in 
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differentiated cells. To assess the ubiquitination status of ZFP809 FL and mutants, the in vivo 
ubiquitination assay was performed with vectors ZFP809 FL, ZFP809(K391A) and 
ZFP809(1-353). Western blotting showed that ZFP809(K391A) is also polyubiquitinated but 
the ubiquitination level is lower than that of ZFP809 FL (Figure 18), which consists with the 
observation that those mutations are comparatively stable than ZFP809 FL in differentiated 
cells. Interestingly, ZFP809(1-353) is mainly monoubiquitinated (Figure 18). 
Monoubiquitination is not a signal for protein degradation, which explains that ZFP809(1-
353) is very stable in differentiated cells.  
2.4.5 Trim28 promotes the degradation of ZFP809 
          Full-length ZFP809 protein is relatively stable in stem cells but not in differentiated 
cells, which indicates that there may be a factor in differentiated cells that could specifically 
target ZFP809 to the ubiquitin-dependent protein degradation. Usually the specificity of 
substrate selection is determined by the E3 ligases. Trim28, which binds to the KRAB box of 
ZFP809, is a RING domain containing proteins and has been shown to serve as an E3 ligase 
(Liang et al., 2011).  RING domain containing proteins, are a large family of E3 ligases and 
usually associate Cullin proteins to form the Cullin-Ring ligases (CRL) complexes (Bennett 
et al., 2010). Cullin proteins serve as a scaffold for protein degradation. Neddylation of Cullin 
proteins results in structural change on those proteins, which allow the transfer of ubiquitin 
proteins from E2, E3 ligases to substrates (Rabut and Peter, 2008). To test the role of Trim28 
in the degradation of ZFP809 in differentiated cells, we used siRNA to knock down Trim28 
75 
 
in 293A cells (Figure 19A). Protein degradation assays showed that ZFP809 (FL) was 
stabilized in Trim28 depleted cells by siRNA (Figure 19B), which suggests that Trim28 plays 
a role in ZFP809 degradation. 
          It has been previously shown that substitution of the amino acids DV with alanine 
residues in KRAB box of zinc finger proteins would abolish the interaction between KRAB 
box and Trim28 (Peng et al., 2000). To investigate the relevance of ZFP809-Trim28 
interaction and ZFP809 degradation, we mutated the DV residues in the KRAB box of 
ZFP809 to make ZFP809(DV-AA). Exogenous expressed ZFP809 in 293T cells successfully 
pulled down Trim28 but not ZFP809(DV-AA) (Figure 20A), which indicates the interaction 
between Trim28 and ZFP809 has been abolished. Protein degradation assay showed that 
ZFP809(DV-AA) degraded in a much slower rate than wild-type ZFP809  (Figure 20B and 
C). The ubiquitination level of ZFP809(DV-AA) is much less than that of ZFP809(FL), 
which explains that ZFP809(DV-AA) is relatively stable over ZFP809(FL) (Figure 18). 
Those observations suggest that interaction between ZFP809 and Trim28 is essential for the 
degradation of ZFP809.  
        Overall, depletion of Trim28 or abolishing the interaction between Trim28 and ZFP809 
stabilized full-length ZFP809 in differentiated cells, suggesting that Trim28 can promote the 
degradation of ZFP809 in differentiated cells.  
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2.4.6 Neddylation inhibitor MLN4924 stabilizes ZFP809 
          Trim28 is a RING domain containing protein, a large protein family that have been 
shown to assemble with multi-subunit Cullin proteins to form Cullin-Ring E3 ubiquitin ligase 
(CRL) complexes (Sarikas et al., 2011). Neddylation activates the CRL complexes and 
promotes their protein degradation activities (Merlet et al., 2009). A small drug MLN4924 
was shown to block the neddylation activity of nedd8, which is required for the activation of 
cullin proteins to target proteins for degradation (Garcia et al., 2014; Godbersen et al., 2014). 
To test if the neddylation is important for ZFP809 degradation, we performed protein 
degradation assay with the neddylation inhibitor MLN4924. MLN4924 or DMSO was added 
with CHX in the experiment. Immunoblotting showed that MLN4924, but not DMSO, 
stabilized the ZFP809(FL) in differentiated cells (Figure 21). As MLN4924 blocks the 
neddylation activities, the stabilization of ZFP809 by MLN4924 indicates that neddylation is 
important for the degradation of ZFP809, suggesting that CRL may be involved in the 
degradation of ZFP809.  
2.5 Discussion 
          ES cells and other primitive cell types exhibit unusual mRNA profiles, and much of 
their specific patterns of gene expression can be attributed to unusual chromatin 
modifications and transcriptional activity of their genomic DNAs. However, these cells also 
exhibit unusual patterns of global protein modifications including ubiquitinylation (Sutovsky 
et al., 2001), and indeed the very maintenance of their pluripotency requires unusual profiles 
77 
 
of ubiquitinylation and proteosomal degradation (Buckley et al., 2012) (van der Stoop et al., 2008) 
(for review, see (Naujokat and Saric, 2007)).  In this study, we found that the ZFP809 protein, 
the key component of a retroviral silencing complex, is regulated by the proteasomal protein 
degradation system.  
          ZFP809 protein is expressed in ES cells but not in most differentiated cells and is 
responsible for the rapid and efficient silencing of exogenous (Wolf and Goff, 2009) and 
endogenous (Wolf et al., 2015) retrovirus DNAs in ES cells. Ectopic expression of ZFP809 in 
murine or human differentiated cells is sufficient to establish silencing of MLV proviruses, 
suggesting that it is the limiting factor and that all other components of the silencing 
machinery are present in most cells. Surprisingly, the levels of ZFP809 mRNAs are 
comparable In ES cells and differentiated cells. We found that the full-length ZFP809 protein 
is subject to ubiquitin-mediated degradation in most cells, but is uniquely stable in ES and EC 
cells. Thus, unlike many targets of ubiquitinylation and degradation in ES cells, ZFP809 is 
protected from or resistant to such regulatory events in these cells. 
         A curious feature of the ZFP809 gene is that its transcription results in the formation of 
two alternatively spliced mRNAs that encode two forms of the protein, a full-length and a C-
terminally truncated form. Both mRNAs are expressed in ES and differentiated cells, with the 
mRNA for the full-length protein being by far the more abundant in both cases. Expression of 
cDNAs revealed that the full-length protein is the regulated form, selectively stable in ES 
cells and degraded elsewhere. The C-terminal 50 residues, and lysine391 in this sequence in 
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particular, are required for degradation. It is unclear why the two forms are made; both forms 
of the protein retain the KRAB domain for interaction with Trim28, and the zinc fingers 
required for DNA binding, and the short form seem to have full functionality in silencing. 
Why low levels of the truncated form would be expressed constitutively is not apparent. 
          Another surprising aspect of the system is the involvement of Trim28 in the regulation 
of the levels of ZFP809. The major function of the interaction between ZFP809 and Trim28 
is to bring Trim28 and all its associated factors to the target DNA to mediate the silencing 
through chromatin and DNA modification. The interaction would be expected to result in the 
stabilization of ZFP809. But in differentiated cells, the interaction is actually involved in the 
destabilization of ZFP809. The results suggest that Trim28 is playing a major role in keeping 
ZFP809 levels low in differentiated cells. Trim28 may be acting as the E3 ligase directing the 
ubiquitinylation of ZFP809, or it may be acting indirectly, but depleting Trim28 or 
preventing the interaction with ZFP809 significantly reduces the rate of ZFP809 degradation. 
How its destabilizing activity is restricted to differentiated cells, and is prevented from 
functioning in ES cells, remains unclear.   
          The addition of MG132 stabilizes ZFP809 and results in the accumulation of heavily 
polyubiquitinylated protein, strongly suggesting regulation by ubiquitin-dependent 
proteasomal degradation. Tests of mutant forms of the protein for ubiquitin content suggest 
that eliminating the interaction with Trim28 by mutation (in ZFP809(DV-AA)), removing 
lysine391 by mutation (in K391A), or removing the C-terminus region (in ZFP809(1-353)) 
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all reduce the levels of polyubiquitin many fold, though some of the modification remains. 
The continued modification of K391A and the truncated ZFP809(1-353) indicates that other 
lysines are serving as secondary targets for ubiquitinylation when K391 is not present. The 
truncated protein seems to be largely monoubiquitinylated, and as such would not be 
recognized by the proteosome for degradation. 
          Many ring-finger proteins such as Trim28 function as E3 ligases in concert with one of 
the cullin proteins to target proteins for degradation.  The cullins in turn often require 
modification by addition of Nedd proteins, neddylation, for their functionality (Merlet et al., 
2009). The stabilization of ZFP809 by addition of the neddylation inhibitor MLN4924  
suggests that a cullin protein is likely involved in Trim28-mediated degradation of ZFP809. It 
is not known which cullin or cullins are involved. 
              ZFP809 is not the only protein involved in MLV silencing that is tightly regulated in 
ES cells, and indeed the levels and activity of Trim28 are also subject to complex regulation. 
The PHD domain of Trim28 functions as an intramolecular E3 ligase that sumoylates the 
adjacent Trim28 bromodomain, and this modification is required to recruit the SETDB1 
histone methylase to effect transcriptional silencing (Ivanov et al., 2007). Phosphorylation of 
Trim28 is also required for its function in transcription repression (Li et al., 2007). The active 
Trim28, once phosphorylated and sumoylated, has a shorter half-life and is targeted for 
degradation by RNF4 (Kuo et al., 2014). This pattern of behaviors suggests that after silencing 
a specific chromatin region, Trim28 function is subsequently turned off. The continued 
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presence of Trim28 may not be required to maintain the silencing of MLV in stem cells.  
Once silenced, the proviruses cannot be activated during differentiation, because the 
restriction complex has already placed many silencing marks on the proviral DNA (Yao et al., 
2004). 
          Retroviral DNAs are subject to profound regulation in ES cells and during their 
differentiation. This may be in part to prevent genotoxic expression of exogenous and 
endogenous proviruses, but it is also likely a reflection of the fact that viral transcriptional 
elements have been coopted by the host for the regulation of cellular genes important for 
maintenance of the pluripotent state and for appropriately timed gene expression during their 
differentiation (Robbez-Masson and Rowe, 2015; Rowe et al., 2013). While much of this 
regulation is at the level of transcription, the observations of ZFP809 here suggest that much 
of this regulation may be controlled at a higher level by protein turnover. A full 
characterization of “stemness” – the pleuripotent state – will thus likely require a detailed 
knowledge of the ubiquitin ligase substrates, and more generally the machinery that adds and 


















Figure 8 The mRNA expression levels of ZFP809.  
A) The cell lines, B cell, MEF (mouse embryonic fibroblast), and ES (embryonic 
stem) were generated from ROSA26–M2rtTA mice (Beard et al., 2006). IPS 
(induced pluripotent stem) cells were induced from MEFs. Expression data were 
generated from polyA RNA using GeneChip Mouse Genome 430 2.0 Arrays 
(Affymetrix). Absolute values were normalized by Robust Multi-Array (RMA) 
and processed using Genepattern (Mikkelsen et al., 2008).  B) The mRNA 
expression levels of ZFP809 in selected mouse tissues from BioGPS database. C) 
Real time-quantitative PCR measure of ZFP809 mRNA in mouse EC (F9), ES 
(E14) and fibroblast cells (NIH3T3). The expression level of ZFP809 was 


















Figure 9 Expressing ZFP809 (FL) results in less colonies.  
ZFP809(FL) and ZFP809(1-3530 were cloned to pcDNA3 3XFlag vector. 2ug 
of empty vector or vectors expressing ZFP809(FL) or ZFP809(1-353) were 
transfected into NIH3T3 cells. 48 hours after transfection, cells were selected 


















Figure 10 Expression of ZFP809 proteins in differentiated cells.  
A) 2 ug vectors of pcDNA3 3X Flag empty vector,  ZFP809(1-
353) or ZFP809(FL) were transfected into 293T cells. 24 hours 
after transfection, cells were lysed and subject to immuoblotting 
with anti-Flag antibody. B) 2ug of vector of pLVX 3XFlag 
ZFP809(FL) or ZFP809(1-353) IRES mCherry were transfected 
into 293T or NIH3T3 cells. Samples were analyzed by 


















Figure 11 Elements of ZFP809 mRNA do not regulate luciferase expression.  
A) The 3’UTR, CDS, 5’UTR or a scramble sequence were cloned into 
pcDNA3 Renilla luciferase vector after the Renilla luciferase stop codon. B) 
Vectors were transfected into cells with a control of Firefly luciferase.  
Renilla luciferase units are normalized to firefly luciferase units to calculate 


















Figure 12 ZFP809(FL) is rapidly degraded in 293T cells.  
A) Protein degradation assay. Plasmids expressing flag-tagged 
ZFP809(FL) or ZFP809(1-353) were transfected into 293T cells. 24 
hours after transfection, CHX were added with a final concentration 
50ug/ml to stop translation. Cell lysates were collected after 0, 10min, 
30min, 1h, 2h and 3h after CHX addition and probed by western 
blotting. B) The intensity of each band in figure 12A was measured by 
ImageJ. Relative intensity was calculated by the intensity of each band 
dividing the intensity of band at time 0. The degradation curve of 


















Figure 13 ZFP809 is stable in mouse stem cells.  
Protein degradation assay was performed in E14 cells. 24 hours 
after transfecting pcDNA3 CMV 3XFlag ZFP809(FL) into ES 
cells, cells were treated in 500nM of Trichostatin A (TSA) and 
0.1mM of forskolin (FSK) for 4 hours before CHX was added. ES 
cells transfected with pLVX EF1α 3XFlag ZFP809(FL) were not 
treated with TSA and FSK. Cell lysates were collected at the 



















Figure 14 C terminus of ZFP809 is not sufficient to induece turnover of other 
proteins.  
A) C terminus of ZFP809 was appended to EGFP to make EGFP-C50. DNAs 
expressing ZFP809(FL), EGFP and EGFP-C50 were transfected into 293T cells for 
protein degradation assay. B) Renilla luciferase was tagged with C terminus of 
ZFP809 to make Renilla C50. Renilla luciferase and Renilla C50 were transfected 
into 293T cells with Firefly luciferase as contol. Cycloheximide was added to stop 
translation for 3 hour. Cells were lysed and tested  for luciferase units. Renilla 


















Figure 15 MG132 stabilized ZFP809(FL) in 293T and Rat2 cells.  
A) MG132(30uM), chloroquine(100uM) or DMSO was added with 
CHX to perform protein degradation assay . Cells lysates were collected 
at indicated time points and subjected to immuno-blotting with anti-
Flag and anti-Tubulin antibodies. B) The intensity of each band in 
figure 15A was measured by ImageJ. Relative intensity was calculated 
by the intensity of each band dividing the intensity of band at time 0. C) 


















Figure 16 Mutating of lysine 391 to alanine stabilized ZFP809.  
A) DNAs  expressing flag-tagged ZFP809(FL) and 
ZFP809(K391A)  were transfected into 293T cells to perform 
protein degradation assay. B) The intensity of each band in figure 
16A was measured by ImageJ. Relative intensity was calculated 
by the intensity of each band dividing the intensity of band at 


















Figure 17 ZFP809 is heavily ubiquitinated.  
Vectors expressing flag-tagged p53 or ZFP809(FL) were co-
transfected into 293T cells with  plasmid express his-ubiquitin. 24 
hours after transfection, MG132 was added to stop the protein 
degradation for 4 hours and cells were lysed in buffer A and 
sonicated. Cell lysates was incubated with Ni-NTA agarose for 4 
hours. Then agarose was washed with buffer A, buffer B and buffer 
C. Bound proteins were subjected to immuno-blotting. 10ul of p53 


















Figure 18 ZFP809(1-353) , ZFP809(K391A)  and ZFP809(DV-AA) are 
ubiquitinated in 293T cells.  
In vivo ubiquitination assay was performed as described in Figure 17 with 



















Figure 19 Trim28 promotes ZFP809 degradation.  
A) Trim28 was depleted by siRNA. 293A cells were transfected with 
control siRNA and Trim28 siRNA twice. Cells were analyzed by 
immunoblotting with anti-Trim28 antibody. B) ZFP809(FL) was 



















Figure 20 ZFP809(DV to AA) is relatively stable in 293T cells.  
A) Vectors expressing flag-tagged ZFP809(FL), or ZFP809(DV-AA) 
or empty vector were transfected into 293T cells. 24 hours after 
transfection, cells were lysed in IPH buffer. Cell lysates were 
incubated with anti-Flag magnetic beads overnight. Bound proteins 
were probed by western blotting. B) Protein degradation assay with 
DNAs expressing flag-tagged ZFP809(FL) and ZFP809(DV-AA). C) 
The intensity of each band in figure 20B was measured by ImageJ. 
Relative intensity was calculated by the intensity of each band 




















Figure 21 Neddylation inhibitor MLN4924 stabilized ZFP809(FL).  
MLN4924 (1uM) or DMSO was added with CHX. Cell lysates were 
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Chapter 3  




        It has been known for over thirty years that the replication of Moloney Murine 
Leukemia Virus (MLV or MLV) is restricted in mouse embryonic stem (ES) and embryonic 
carcinoma (EC) cells (Teich et al., 1977). The restriction is targeted to a short DNA sequence, 
primer binding site (PBS) of MLV. The restriction requires the association of a zinc finger 
protein ZFP809 to the PBS(Wolf and Goff, 2009), which recruits Trim28 and other 
transcription factor to block the transcription of retroviral genes. Here we found that a protein 
called L1td1/Ecat11 could associate with Trim28. Depletion of L1td1 by shRNA or knockout 
can partially relieve retroviral restriction occurring at PBS in embryonic carcinoma cells and 
stem cells. 
3.2 Introduction 
         The replication of Moloney Murine Leukemia virus (MLV or MLV) is efficient in most 
permissive dividing cells, but is restricted in mouse embryonic stem (ES) and embryonic 
carcinoma (EC) cells(Barklis et al., 1986). The retroviral DNAs integrate into the host 
genome successfully after infection, but the transcription of retroviral genes from LTR is 
potently silenced (Franz et al., 1986; Linney et al., 1984). The presence of the so-called 
repressor binding site (RBS) is essential for the restriction (Hilberg et al., 1987; Linney et al., 
1984), which shows overlap with the primer binding site (PBSpro) of retroviral DNA (Barklis 
et al., 1986; Feuer et al., 1989; Loh et al., 1987).  The RBS alone is sufficient to induce the 
silencing in a position and orientation- independent manner in mouse ES and EC cells. A 
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single mutation in the RBS sequence is able to abolish the restriction (Loh et al., 1990; 
Petersen et al., 1991). On such mutation, termed PBS B2, consists of a single base change 
near the center of the PBS. Electrophoretic mobility shift assays (EMSA), using the RBS 
sequence as probe, demonstrated the presence of stem-cell specific factors that fulfill the 
requirements for the silencing complex (Loh et al., 1990; Petersen et al., 1991). The 
recruitment of trans-acting repressors to the RBS introduces chromatin modifications, and 
then initiates and maintains the silencing (Akgun et al., 1991; Flanagan et al., 1989; Niwa et 
al., 1983; Schlesinger et al., 2014; Tsukiyama et al., 1989). The key components of the trans-
acting complex were identified by our lab as ZFP809 and Trim28 (Wolf and Goff, 2007, 
2009). ZFP809 binds to the RBS and initiates the silencing of incoming retroviral DNA (Wolf 
and Goff, 2009). It recruits Trim28 by the KRAB box domain and then other transcription 
factors (Wolf and Goff, 2009), such as HP1gamma (Wolf et al., 2008) and ESET (Matsui et 
al., 2010) to silence the retroviral DNAs.  
         Trim28, also known as TRIM28 (KRAB-associated protein 1), is an unusual member of 
the Trim (tripartite motif-containing protein) family. Trim28 interacts with many proteins 
involved with transcriptional repression and silencing, such as the NuRD complex (Rowe et 
al., 2013), HP1 (Wolf et al., 2008), ESET (a histone H3 lysine 9 methyltransferase)(Le 
Douarin et al., 1996; Schultz et al., 2002; Schultz et al., 2001), and EBP-1 (Wang et al., 2014). 
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It is known as a co-repressor of the large family of KRAB (Krüppel-associated box) domain-
containing zinc finger transcription factors (Friedman et al., 1996).  
          F9 nuclear extract was prepared and the activity was precipitated with 40% ammonium 
sulfate. The recovered precipitate was applied to a butyl sepharose hydrophobic interaction 
column and a Sephacryl S-500 gel filtration column. The peak elution was 
coimmunoprecipitated with anti-Trim28 antibody and bound proteins were subject to mass 
spectrometry analysis. L1td1 was an interesting protein identified with higher abundance than 
ZFP809 (table 1) (Wolf and Goff, 2009). 
         L1td1 (LINE1 type transposase domain containing 1), homologous to the ORF1 protein 
of LINE1, was initially identified as ECAT11 (ES cell-associated transcripts 11), in a digital 
differential display analysis (DDD) of the expressed sequence tag libraries among various 
mouse tissues and cell lines (Mitsui et al., 2003). L1TD1 is highly expressed in 
undifferentiated cells, and could be used as a marker for undifferentiated cells.  It is also a 
downstream target of the differentiation gene Nanog (Wong et al., 2011). L1TD1 localizes in 
P-bodies and is required for the renew of human embryonic stem cell(Narva et al., 2012). 
Perhaps surprisingly, L1td1 is not required for the induction and maintenance of pluripotency 
in mouse (Iwabuchi et al., 2011).  
          In this work, we found out that L1td1 interacts with Trim28 and ZFP809 in 
endogenous level. Purified GST-tagged L1td1 and its truncations can also pull down 
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endogenous L1td1 in F9 cells. In vitro protein-protein interaction assay using MBP-tagged 
L1td1, GST-tagged ZFP809 and GST-taggedTrim28 showed that L1td1 interacts with 
Trim28, probably not ZFP809, indicating that the interaction between ZFP809 and L1td1 we 
observed might be bridged by Trim28. The interactions suggest one mechanism by which 
L1td1 helps the silencing of retrovirus DNAs in mouse ES and EC cells. Depletion of 
L1td1by shRNA in F9 cells or knockout in ES cells could partially relieve the restriction of 
MLV occurring at the PBS. 
3.3 Methods 
3.3.1 Cell culture 
          RAT2 and 293T cells were cultured in DMEM with 10% FBS and L-glutamine, 
penicillin and streptomycin. F9 cells were cultured in DMEM with 10% FBS, L-glutamine, 
penicillin and streptomycin. Plates were coated with 0.1% gelatin. Mouse L1td1 wildtype and 
knockout cells were kindly provided by Dr. Yamanaka in Tokyo University (Iwabuchi et al., 
2011). Mouse ES cells were cultured on deactivated mouse MEFs with DMEM with 20% 
defined FBS, nonessential amino acids, 2uM sodium pyruvate, penicillin and streptomycin, 
and 1000 units of mouse leukemia inhibitory factor (LIF). Cells were transferred to plates 





          The oligonucleotides, vectors and restriction sites for cloning GST-tagged ZFP809, 
Trim28 and MBP-tagged L1td1 are listed below. Oligonucleotides for shRNA-mediated 
knockdown of L1td1 were cloned into the pSuper Retro zeo vector using the BglII and XhoI 
cloning sites according to standard protocols (Oligoengine). The Moloney MLV vectors with 
neomycin or puromycin reporter were described before (Wolf and Goff, 2007). 
Oligonucleotides for cloning pGEX2TPL ZFP809 
BamH1  agtc GGATCC ACC ATGGGGTTGGTGTCCTTTGAG 
EcoR1  agct AGATCT TCAGAATTCAGCTAGATCTTCAGAATTC 
pGEX2TPL ZFP809(1-353) 
BamH1  agtc GGATCC ACC ATGGGGTTGGTGTCCTTTGAG 
EcoR1 agct GAA TTCTCA ACGCGTAAAGTACGTTACCCCTG 
pGEX2TPL ZFP809 60-236 
BamH1  atgc GGATCC  TTTGGGCCATGGAGCCTAGC 
EcoR1 agct GAATTC TTATGAATGGGTTCTTTCATGG 
pGEX2TPL ZFP809 151-293 
Xba1  atgc TCTAGA GATGGGAATCTCTATGAATG 
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EcoR1  atgc GAATTC TTAGCCCGTATGTTTCTTCTG 
Oligonucleotides for cloningpMAL C2 L1td1 
Xba1  GCTTGCCTGCAGGTCGACTCTAGACTAATGTATATTGTTCAACAGATCTTTC 
EcoR1  ATCGAGGGAAGGATTTCAGAATTCTCGGGCGTGCAGTCCAA 
Oligonucleotides for shRNA  
L1td1  AGGAAGAAGTGAACAGAAA 
Scrambled  GGTGCCGTTTAGTAGTACA  
Negative control CAGCAGCCATGTCCTGAAA  
3.3.3 Co-immunoprecipitation of endogenous proteins 
         The preparation of F9 cell lysates was as described previously (Wolf and Goff, 2007). 
F9 cells were lysed in 750 μl IPH buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8, 0.5% 
Nonidet P-40, 5 mM MgCl2 1 mM CaCl2 0.5 mM EDTA, + protease inhibitors [Complete, 
Roche]). The lysates were then treated with 100 U DNase (Roche) and RNase (Life 
Technologies) for 24 h at 4°C. Coimmunoprecipitations were performed using 5 μg of 
antibodies and a mixture of 20 μl protein A and 25 μl protein G Dynabeads (Invitrogen). 
Bound proteins were eluted with Laemmli buffer, displayed by PAGE and blotted, and the 
Western blots were probed with anti L1td1 and anti TRIM28 antibodies  
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3.3.4 GST pulldown assay  
        E.coli BL21 cells, transformed with vectors expressing GST tagged proteins, were 
cultured at 30
o
C and induced with IPTG at OD 0.6 for 6 hrs. Cells were sonicated and spun 
down at 12000 x rpm for 30 min. Supernatants were collected and incubated with glutathione 
magnetic beads at 4
o
C for 2 hrs or overnight. The beads, now coated with GST tagged 
proteins or GST, were then added to F9 EC cell lysates. F9 cells were lysed in IPH buffer 
(Wolf and Goff, 2009). After incubation, beads were washed and eluted with Laemmli buffer. 
The eluted proteins were analyzed by Western blotting with anti-GST or anti L1td1 
antibodies.  
3.3.5 Protein-protein interaction assay 
          E.coli BL21 cells, transformed with vectors pMAL C2 or pMAL C2 L1td1, were 
cultured at 30
o
C and induced with IPTG at OD of 0.6 for 6 hrs. The preparation of MBP-
L1td1 supernatant was according to the standard protocol form New England Biolabs. Cells 
were sonicated and spun down at 12000 x rpm for 30 min. Supernatants were collected and 
incubated with amylose beads at 4
o
C for 2hrs or overnight. The beads coated with MBP or 
MBP-L1td1 were added to supernatant containing GST, GST-ZFP809, GST-Trim28, 
prepared from bacteria expressing the appropriate GST proteins. Bound proteins were subject 
to western blotting analysis using anti-GST and anti-MBP antibodies.   
3.3.6 Generation of L1td1 stable knockdown F9 cell line 
          VSV-G-pseudotyped viral particles were generated by transfecting three plasmids —
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pMD.G, pCMV Intron and vectors with shRNA oligos or reporter genes – into 293T cells. 
Supernatants were collected after 48-72 hrs and filtered through a 0.25 um filter. F9 cells 
were infected by the supernatant and put in 200 uM zeocin selection after 48 hrs for 7 days to 
generate the L1td1 knockdown cell lines. The knockdown was confirmed by western blotting 
with antiL1td1 antibody generated by Dr. Daniel Wolf in our lab.  
3.3.7 Real time PCR 
          RNA was harvested from L1td1 wildtype and knockout ES cells utilizing TRIzol 
(invitrogen). cDNA was generated from RNA using SuperScript III Reverse Transcriptase 
(Invitrogen) and L1td1 and other gene levels were then quantified by Q-PCR (FastStart 
Universal SYBR Green Roche). Primers for Q-PCR are listed here (Left 5’, right 3’).  
L1td1 forward AAACGAGCTTCGGGAAAGAT  
L1td1 reverse GGAAGCTCAAACTGTCACTCG 
GAPDH forward ACCTTTAGCCTTGCCCTTT 
GAPDH reverse ACATCACCCCCATCACTCAT 
Oct-4 forward GGCGTTCTCTTTGGAAAGGTGTTC   
Oct-4 reverse CTCGAACCACATCCTTCTCT   
Nanog forward  AACCAAAGGATGAAGTGCAAGCGG  
Nanog reverse  TCCAAGTTGGGTTGGTCCAAGTCT 
Endogenous MLV forward   TAGATGGAGCCTACCAAGCTCTCAA 
Endogenous MLV reverse    AGAGGTATGGTTGGAATAAGTA 
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IAP forward  AAGCAGCAATCACCCACTTTGG 
IAP reverse  CAATCATTAGATGYGGCTGCCAAG 
Line forward  AGAGGTATGGTTGGAATAAGTA 
Line reverse  CCATGTTTAGCGCTTCCTTC 
MusD forward  GTGCTAACCCAACGCTGGTTC 
MusD reverse CTCTGGCCTGAAACAACTCCTG 
3.3.8 Genomic PCR 
          Mouse ES genomic DNA was prepared from the protocol in (Truett et al., 2000). The 
genotyping PCR primers are from (Iwabuchi et al., 2011). The PCR cycle is 95oC for 1min, 
65oC for 30s, 72
o
C for 1min with 35 repeats.  
3.3.9 Viral transduction assay 
          VSVG pseudotyped viral particles were generated by transfecting three plasmid—
pMD.G, pCMV Intron and vectors with neomycin or puromycin-resistance reporter genes – 
into 293T cells. L1td1 knockout or knockdown cells were infected by VSV-G pseudotyped 
MLV viral particles with neomycin or puromycin reporter. 48hrs after infection, cells were 
selected in 1mg/ml neomycin for 10-14 days or 1ug/ml puromycin for 7 days. Colonies were 




3.4.1 L1td1 is homologous to ORF-1 of L1 
          L1td1 (LINE1 type transposase domain containing 1), homologous to the ORF1 protein 
of LINE1, was identified as ECAT11 (ES cell-associated transcripts 11), in a digital 
differential display analysis (DDD) of the expressed sequence tag libraries among various 
mouse tissues and cell lines (Mitsui et al., 2003). L1TD1 protein is enriched in 
undifferentiated cells, and could be used as a marker for undifferentiated cells. The predicted 
open reading frame of L1td1 shows a similarity to ORF-1 of Line1, a very abundant non-LTR 
retrotransposon in human and mouse genomes (Doucet et al., 2010; Singer, 1982). Sequence 
alignments of L1td1 to the NCBI database revealed the presence of two transposase 22 
domains, which also have identity to the ORF-1 protein (Figure 22).  The transposease 22 
domain of ORF-1 is responsible for RNA binding (Martin, 2006), suggesting that  L1td1 
might have RNA binding ability. Homologs of L1td1 can be identified in human, rat and 
other species, but the overall sequence similarity is low (Figure 22).   
3.4.2 L1td1 interacts with both Trim28 and ZFP809 
          The original identification of ZFP809 as the PBS-specific DNA binding activity 
involved several purification steps that enriched for the silencing complex. L1td1 was 
identified along with ZFP809 in the complexes immunoprecipitated with Trim28 specific 
antibody (Wolf and Goff, 2009), which indicates L1td1 may interact with Trim28 or ZFP809. 
To confirm the authenticity of the interactions of L1td1 with Trim28 or ZFP809, lysates from 
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an EC cell line F9, were subjected to immunoprecipitation with either anti-L1td1 antibody or 
anti-ZFP809 antibody. The bound proteins were resolved by SDS-PAGE and analyzed by 
immunoblotting with anti-Trim28 or anti-L1td1 antibodies. Endogenous Trim28 was detected 
in both anti-L1td1 and anti-ZFP809 immunoprecipitates but not the IgG control (Figure 23). 
This observation shows that Trim28 and L1td1 interact at their endogenous levels of 
expression. As previously reported, ZFP809 was able to bind Trim28. A weak band of L1td1 
was detected in the anti-ZFP809 immunoprecipitates, which indicates that L1td1 might also 
interact with ZFP809. All of the interactions are resistant to depletion of nucleic acids by 
adding nucleases (Figure 23), suggesting that the interactions of L1td1-Trim28 and ZFP809 -
Trim28 are not mediated by nucleic acids. Due to the poor quality of anti-ZFP809 antibody, 
and to the similarity of ZFP809 and IgG molecular weights, ZFP809 was not detected by 
immunoblotting (Figure 23).  
          To verify the interaction between ZFP809 and L1td1, ZFP809 truncations tagged with 
GST protein were made (Figure 24A). Glutathione beads coated with bacterially-expressed 
GST-tagged ZFP809 and its truncation derivatives were incubated with F9 cell lysates. The 
bound proteins were subjected to immunoblotting analysis. L1td1 was detected in all GST-
ZFP809 precipitates but not the GST control, indicating that ZFP809 can interact with 
endogenous L1td1 (Figure 24B). The observation also indicates that the region from 151 to 
236 of ZFP809 is important for the interaction of L1td1 and ZFP809. Overall, the 
observations suggest that L1td1 interacts with both Trim28 and ZFP809.  
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         These precipitation assays showed that L1td1 interacts with Trim28 and ZFP809, but it 
is not sufficient to conclude that L1td1 interacts with them directly since ZFP809 binds to 
Trim28 endogenously. To test if L1td1 binds to Trim28 and ZFP809 directly, bacteria 
expression vectors of MBP-tagged L1td1 and GST-tagged Trim28 and ZFP809 were made. 
MBP-L1td1 expressed in bacteria was bound to amylose beads and incubated with 
supernatants containing GST-tagged Trim28 or ZFP809. Bound proteins were subjected to 
immuno-blotting analysis using anti-GST antibody. The blotting showed that MBP-L1td1 
could pull down GST-Trim28 but not GST-ZFP809. MBP and GST tags didn’t pulldown 
other proteins or each other (Figure 25). The observation indicates that L1td1 interact with 
Trim28 directly. The interaction between ZFP809 and L1td1 we observed before might be 
bridged by Trim28.  
3.4.3 Depletion of L1td1 partially relieves the MLV restriction in EC and ES cells 
          To investigate the functional relevance of the Trim28-ZFP809-L1td1 for PBS-mediated 
silencing, we used short hairpin RNA (shRNA, a modified siRNA system) to knock down the 
L1td1 levels in F9 cells. Successful depletion of L1td1 was achieved (Figure 26A). As 
negative control, cell lines expressing scrambled or negative shRNA were generated. To 
quantify the level of PBS-mediated repression, we made use of transducing MLV reporter 
viral particles expressing neomycin resistance. We compared the titer of a wild-type MLV 
(MLV-WT) reporter utilizing the wild-type PBS to an MLV-B2 reporter utilizing a mutant 
PBS (B2) escaping PBS-mediated silencing. The two viruses were used to infect the various 
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cell lines outlined in Figure 26B and cells were then selected with G418 for 2 weeks before 
colony counting. The ratio of the number of B2 colonies to WT colonies represents the 
degree of the fold of PBS-mediated silencing. As expected, in wild-type cell line, or cell lines 
expressing scrambled and negative, a B2/WT ratio close to 25 was observed (Figure 26B). In 
contrast, the B2/WT ration in L1td1-depleted cell line was around 6 fold. Thus, the L1td1 
depletion in F9 cells caused a roughly 4-fold reduction in PBS-mediated restriction, 
indicating the functional importance of L1td1 in the ZFP809-TRIM28 complex. To verify the 
pluripotency of F9 cell upon depletion of L1td1, we tested the mRNA levels of two well-
known markers of stem cells, Oct4 and Nanog. Semi-quantitative RT-PCR showed that 
depletion of L1td1 does not affect the expression level of those factors (Figure 26C), 
indicating the depletion of L1td1 may not disturb the pluripotency of F9 cells.  
          We also analyzed L1td1 knockout cell lines derived from C57BL/6 mouse, and kindly 
provided by Dr. Yamanaka from Kyoto University (Iwabuchi et al., 2011). To confirm the 
deletion of L1td1 gene, primers covering the L1td1 gene region were designed for genomic 
PCR. WT L1td1 will give a band of 17.2 Kb and knockout will give a band of 14.3 kb. 
Genomic PCR showed that L1td1 had been successfully deleted (Figure 27A). Viral 
transduction assays were performed using MLV particles pseudotyped with VSVG protein, 
transducing the neomycin or puromycin resistance genes and utilizing either the PBS pro or 
gln variants. The PBS gln is a variant PBS that is not recognized by ZFP809. In both of two 
L1td1 knockout cell lines, the PBS-mediated silencing is relieved approximately 4 fold, 
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which is consistent with the observations in the knockdown cell line (Figure 27B). 
Collectively, the observations suggestion that depletion of L1td1 partially relieves the PBS 
mediated restriction of retroviruses.  
3.4.4 Depletion of L1td1 doesn’t affect endogenous retroviruses 
        The previous results suggested that depletion of L1td1 partially relieved the PBS-
mediated restriction of exogenous MLV, and indicates its participation in the RBS silencing 
complex. It has shown recently that ZFP809 is required for the initiation of epigenetic 
modification of endogenous retroviral silencing (Wolf et al., 2015). To measure the effects of 
L1td1 on the activities of endogenous retroelements, we used primers for quantitating the 
RNA levels of several endogenous retroelements, endogenous MLVs, IAPs, LINEs and 
MusD (Herniou et al., 1998; Matsui et al., 2010). Intracisternal A particles (IAP) and MusD 
are retrovirus-like retrotransposons (Aota et al., 1987; Ribet et al., 2007). The expression 
levels of endogenous retrolelements were assessed by reverse transcription-quantitative PCR 
of L1td1 wildtype and knockout ES cells. The levels of mRNA were normalized to that of 
UBC control. The RNA levels of E-MLV, IAP, MusD and Line were comparable between 
the wildtype and knockout cells, indicating that L1td1 might not affect the transcription of 
those families of retrotransposons (Figure 28). 
3.5 Discussion 
          In both human and mouse, L1td1 is highly expressed in undifferentiated stem cells, but 
not in differentiated cell. The expression of L1td1 increases in the process of generating iPS 
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cells and decreases upon differentiation (Wong et al., 2011).  In humans, L1TD1 is essential 
for the maintenance of pluripotency. Depletion of L1TD1 results in a down-regulation of 
OCT4 and NANOG(Emani et al., 2015). Its expression is tightly regulated by binding of 
those stem cell factors to the promoter region (Narva et al., 2012).  Analysis of proteins 
bound to L1td1 in human embryonic stem cells reveals that L1td1 is part of the pluripotency 
interactome network of OCT4, SOX2, and NANOG, and playing an important role in RNA 
splicing, translation, protein traffic, and degradation, bridging nuclear and cytoplasmic 
regulation (Emani et al., 2015). However, L1td1 perhaps is dispensable for the induction and 
maintenance of pluripotency in mouse (Iwabuchi et al., 2011; Mitsui et al., 2003). 
Evolutionary analysis of L1TD1 found that it originated in the common ancestor of placental 
animals, and might have been retained for a role of genome defense against transposable 
element in embryonic cells. L1TD1, rapidly evolving in rodents and primates, has been lost 
in a subset of mammals or been selected for a function transition to pluripotency maintenance 
as in humans (McLaughlin et al., 2014). Our observation of the role of L1td1 in retroviral 
silencing in rodent cells suggests that L1td1 retains partial function of genome defense during 
evolution. 
          In summary, the binding of ZFP809 to MLV PBS ensures the capability of mouse 
embryonic cells to silence MLV. ZFP809, tethered to the proviral DNA, serves as a 
coordinator to recruit the silencing complex, including Trim28, HP1 and others, thereby 
transcriptionally deactivates the incoming viruses. In the report, the finding of L1td1 linking 
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to ZFP809-Trim28 silencing complex expands our understanding of retroviral silencing in 
mouse embryonic cells. Depletion of L1td1 in embryonic cells partially relieves the PBS 
mediated retroviral silencing, which indicates a function of L1td1, a stem-cell specific factor. 
However, the mechanism of how L1td1 promotes retroviral silencing is still not understood. 
Dr. Bestor’s group recently found that L1td1 interacts with the DNA methyltransferase 3-like 
protein, Dnmt3L (not published). Dnmt3L tethers to the N terminus of histone H3 and recruit 
Dnmt3A, another DNA methytransferase (Ooi et al., 2007; Zhang et al., 2010). Dnmt3A and 
Dnmt3B are required for methylation of endogenous retroelements and to establish de novo 
methylation of newly integrated retroviruses, which is important for the initiation and 
maintenance of retroviral silencing (Kao et al., 2014; Liang et al., 2002; Okano et al., 1999). It 
is plausible that L1td1 initiates or promotes the recruitment of Dnmt3L to the newly 
integrated retroviral DNA, and thereby installs long-term methylation markers on the 
provirus. Further study will be necessary to address the relevance of L1td1 and methylation 
of newly integrated retroviral DNA.  
                    Knockdown of L1td1 partially relieves the restriction occurring at the RBS, 
suggesting that it targets mainly PBSpro containing exogenous or endogenous retroviruses. 
The endogenous retrotransposons ERV, IAP and MusD utilize PBS gln, phe and lys 
respectively (Baust et al., 2003; Ono and Ohishi, 1983; Stoye and Coffin, 1987) and the Line 
elements have no PBS (Hardies et al., 2000). That might explain the reason that depletion of 
L1td1 doesn’t affect their RNA levels. Primers targeting only PBSpro containing 
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retrotransposons now are available (Wolf et al., 2015) and could be used to measure the 
effects of L1td1 on endogenous retroviruses. 
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Mouse Protein Identified # Unique Peptides identified
LINE-1 type transposase domain containing 1 14
zinc finger protein 568 9
ATP-dependent RNA helicase DDX3X 6
zinc finger protein 809 5
Eukaryotic translation elongation factor 1 alpha 1 4
















Table 1 Proteins identified by mass spectrometry.  
Sample enriched for silencing complex was immunoprecipitated with anti-
Trim28 antibody and IgG control. Bound proteins were probed by SDS-PAGE 
and displayed with coomassie blue. Bands present exclusively in anti-Trim28 


















Figure 22 Protein sequence alignment of human L1TD1, mouse L1td1 and 
ORF1.  
The sequences of human L1TD1, mouse L1td1 and ORF1 were aligned using 
CLCbio software. Motif 1 and 2 are two homologous domains among those three 


















Figure 23 L1td1 interacts with both endogenous Trim28 and ZFP809.  
Total cell lysates of F9 cells were prepared as described previously 
(Wolf and Goff, 2007). Cells lysates were incubated with IgA and IgG 
beads coated with anti-L1td1 or anti-ZFP809 antibodies in 4
o
C 
overnight. DNase I (1U, invitrogen) and RNase A(100 units, Qiagen) 
were added to indicated samples. Bound proteins were analyzed by 
western blotting using anti-Trim28 (Abcam) and anti-L1td1 antibodies 


















Figure 24 ZFP809 interacts with endogenous L1td1.  
A) ZFP809 contains two conserved domains, KRAB box and zinc 
fingers. Several truncations were made as indicated and appended 
to GST tag. B) GST-tagged ZFP809 proteins pulled down 
endogenous L1td1. Bacterial expressed GST tagged ZFP809 
proteins were bound to glutathione beads. Cell lysates of F9 cells 
were incubated with the beads in 4oC for overnight. Bound 
proteins were subject to 10% SDS-PAGE and western blotting with 


















Figure 25 In vitro protein-protein interaction assay showed L1td1 interacts with 
Trim28 but not ZFP809.  
Amylose beads were coated with bacterial expressed MBP or MBP-L1td1 and 
then incubated with supernatants containing GST, GST-ZFP809 or GST-
Trim28. Bound proteins were eluted with Laemmli buffer and subjected to 


















Figure 26 Depletion of L1td1 in F9 cells partially relieves the PBS-mediated retroviral 
silencing.  
A) Total cell lysates of F9, F9 cell lines expressing scrambled (F9 scram), negative (F9 
negative) and L1td1 knockdown (F9 L1td1 knockdown) shRNAs were subjected to 
immunoblotting with anti-L1td1 and anti-Tubulin antibodies (Abcam). L1td1 knockdown 
shRNAs were cloned into pSuperRetro Zeo vector (Oligoengine).  The sequences are: 
scramble, GGTGCCGTTTAGTAGTACA; non-function, 
CAGCAGCCATGTCCTGAAA; L1td1 knockdown: AGGAAGAAGTGAACAGAAA. 
B, B) cells were infected with vesicular stomatitis virus glycoprotein (VSV G)-





constructs. Reporter gene expression in each cell line was assessed by colony counting 
after G418 selection. Graph shows the ratio of B2/Pro infection efficiency. Results shown 
are means ± standard errors of the means (SEMs) from three independent experiments 
performed in Duplicate. Student's t test was used for statistical analysis. * denotes P < 
0.05, and **  P < 0.01. C), Total mRNA were prepared from cells indicated in the figure 
using TriZol reagent. Quantitative PCR, testing the relative expression level of L1td1 and 
two stem cell genes, Oct4 and Nanog, were performed using Gapdh and CycB as control. 
Gene expression levels were normalized to the control gene. The graph shows the ratio of 


















Figure 27 Knockout of L1td1 relieves the restriction in mouse ES cells.  
A) Genomic PCR showed successful deletion of L1td1. The bands 
representing knockout and wildtype L1td1 are indicated (Iwabuchi et 
al., 2011). B) Viral transduction assay using pseudotyped PBSpro or 
PBSGln transducing a neomycin resistance gene in L1td1 wild-type or 
knockout ES cells. Cells were selected in G418 for two weeks after 
infection. The normalized colony formation unit of P/B2 is about 20 fold 




















Figure 28 Knockout of L1td1 does not affect the RNA levels of several 
retrotransposons.  
Total RNAs were prepared from L1td1 wildtype (L1td1 WT) and knockout 
(L1td1 NL) ES cells. Quantitative real time PCR was performed to assess 
the mRNA level of Endogenous retrovirus (ERV), MusD, IAP and LINE. 
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Addendum to Chapter 3 
 








         It has been known for many years that the replication of Moloney Murine Leukemia Virus 
(MoMLV or MLV) is restricted in mouse embryonic stem (ES) and embryonic carcinoma (EC) cells 
(Barklis et al., 1986). Retroviral infection results in successful integration of proviral DNA, but the 
transcription of the provirus is blocked (Franz et al., 1986; Linney et al., 1984). The presence of so-
called repressor binding site (RBS) is essential for the restriction (Hilberg et al., 1987; Linney et al., 
1984), which shows overlap with the primer binding site (PBSpro) of retroviral DNA (Barklis et al., 
1986; Feuer et al., 1989; Loh et al., 1987). Electrophoretic mobility shift assays (EMSA), using the 
RBS sequence as probe, demonstrated the presence of a stem-cell specific silencing complex (Loh et 
al., 1990; Petersen et al., 1991). The recruitment of trans-acting silencing complex to the RBS 
introduces chromatin modifications, which initiates and maintains the silencing (Akgun et al., 1991; 
Flanagan et al., 1989; Niwa et al., 1983; Schlesinger et al., 2014; Tsukiyama et al., 1989).  
          To purify the silencing complex, EMSA was used to monitor its presence. F9 nuclear extracts 
were precipitated with 40% ammonium sulfate. The recovered precipitate was applied to a butyl 
sepharose hydrophobic interaction column, and then a Sephacryl S-500 gel filtration column. The 
RBS binding complex was eluted from the gel filtration columns in a broad peak, indicative of an 
apparent size ranging from about 2 to 0.7 MDa, and centered on approximately 1.3 MDa (Wolf and 
Goff, 2007). Purified fractions were probed by EMSA and the shifted band defining the complex was 
excised from the gel. The proteins associated with the DNA were analyzed by mass spectroscopy. 
           The key components of the trans-acting complex were identified by our lab as ZFP809 and 
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Trim28 (Wolf and Goff, 2007, 2009). ZFP809 binds to the RBS and initiates the silencing of incoming 
retroviral DNA (Wolf and Goff, 2009). It recruits Trim28 by the KRAB box domain and then other 
transcription factors (Wolf and Goff, 2009), such as ESET (Matsui et al., 2010) and HP1gamma (Wolf 
et al., 2008) to silence the retroviral DNAs.  
          The sum of molecular weights of ZFP809, Trim28, ESET and HP1gamma is less than 0.7MDa, 
which means that there are other factors involving in the silencing complex. Further efforts to identify 
those factors revealed that EBP1 (Wang et al., 2014) and L1td1 might be part of the silencing 
complex. One interesting protein family identified in the initial mass spectrometry was nucleosome 
remodeling deacetylase (NuRD) complex (Table 2).  NuRD complex, identified in 1998 (Tong et al., 
1998), has been shown to regulate chromatin organization, gene transcription, genomic stability and 
developmental signaling (Allen et al., 2013; Basta and Rauchman, 2015; Ramirez and Hagman, 2009).  
          NuRD complex remains the only chromatin remodeler with ATPase and histone deacetylase 
functions (Wade et al., 1998; Xue et al., 1998; Zhang et al., 1998).  it includes enzymatic subunits of 
HDAC1/2 (histone deacetylation complex) and CHD3/4 (chromo domain helicase DNA-binding 
protein) and non-enzymatic proteins, MBD2/3 (methyl-CpG-binding domain), RBBP7/4 
(retinoblastoma-binding proteins), MTA1/2/3 (metastasis-associated) and p66α/β (Allen et al., 2013). 
HDAC1/2 (histone deacetylase) remove acetyl groups (O=C-CH3) from a ε-N-acetyl lysine amino 
acid on histones, allowing the histones to wrap DNAs more tightly (Choudhary et al., 2009). The 
chromo domain helicase DNA-binding protein 3 (CHD3) and CHD4, utilize energy derived from 
hydrolysis of ATP for DNA sliding and repositioning of nucleosomes (Mansfield et al., 2011). They 
contain tandem plant homeodomain fingers (PHDs), which bind to Lys9 (H3K9me3) and displace 
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HP1γ from pericentric sites (Musselman et al., 2009), but recruit other components of NuRD complex 
for transcription repression (Mansfield et al., 2011). MBD2 and MBD3 are members of the methyl 
cytosine-guanosine (CpG)-binding domain (MBD) family proteins. MBD2 and MBD3, which bind 
robustly to methylated DNA, are required for the complex formation and gene repression (Hendrich 
and Bird, 1998; Le Guezennec et al., 2006; Wade et al., 1999).  The retinoblastoma-binding proteins 
RBBP7 and RBBP4 have histone chaperone activity (Murzina et al., 2008; Qian et al., 1993). 
Metastasis-associated gene (MTA) proteins, which are transcription co-regulators, were shown to be 
involved in breast cancer invasion and metastasis (Toh et al., 1994). The p66α and p66β are 
transcriptional repressor proteins (Feng et al., 2002).  
          It has been shown that Trim28 recruits CHD3 and CHD4 to the target for transcription silencing 
(Schultz et al., 2001). The presence of NuRD complex proteins in the shifted band strongly indicates 
that NuRD proteins may involve in the retroviral silencing. NuRD complex has also been shown to be 
recruited by and co-localize with Tet1 (Ten-eleven translocation methylcytosine dioxygenase 1) and 
5hmC (5-hydroxymethylcytosine ) (Yildirim et al., 2011). Tet1 catalyzes the conversion of the 
modified DNA base 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) (Tahiliani et al., 
2009), which has been proposed as the initial step of active DNA demethylation in mammals (Shen 
and Zhang, 2012).  
          To test if NuRD complex and Tet family proteins are involved in the retroviral silencing, we 
cloned small hairpin RNA (shRNA) sequences, which have been shown to specifically knock down 
Mbd3 (Zhu et al., 2009), Mta1 (Jiang et al., 2011), Mta2 (Fu et al., 2011) and HDAC2(Harms and 
Chen, 2007), Tet1(Freudenberg et al., 2012) and Tet2 (Koh et al., 2011) into pLKO.1 vector.  VSV-G 
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pseudotyped viruses, containing those shRNAs were used to infect F9 cells to generate stable knock 
down cell lines. Real-time quantitative PCR showed successful depletion of those proteins (Table 3). 
However, viral transduction assays (described in Chapter 2) using neomycin resistant gene as a 
reporter showed that none of those proteins affect the PBS-mediated retroviral silencing (Table 3). 
          Though depletion of NuRD complex proteins (Mbd3, Mta1, Mta2 and HDAC2) and Tet family 
proteins (Tet1 and Tet2) in F9 cells doesn’t change the restriction fold of P/B2, it is not sufficient to 
conclude that NuRD complex and Tet proteins are involved in the retrovirus silencing. One of the 
reasons may be the redundancy of those proteins. Protein in families of Mbd, Mta, HDAC and Tet, 
have high similarity in sequences and functions to each other. The function of depleted protein may be 
complemented by other members in the protein family. All of the homologs should be depleted to test 
their roles in retroviral silencing. Other assays such as ChIP sequencing could be used to access the 

































Table 2 Proteins identified by mass spectrometry.  
F9 nuclear extract was purified for enriching MLV silencing complex. After last step 
of purification, samples were subjected to electrophoretic mobility shift assay and 
the shifted bands were removed from the gel and processed by mass 
spectrometry(Wolf and Goff, 2009). 
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Genes shRNA sequences Knockdown (By RTPCR) Restrction fold 
Scrambled GCGAAGTGCATTGTGTGGC Non 25
GATGAATAAGAGTCGCCAG Yes 20
AGCCTTCATGGTGACAGAT No 21
Mta2 GGTTGTCTGTCTTTTCCGG Yes 30














Table 3 Small hairpin RNA depletion of components of NuRD complex and 
Tet proteins does not affect the PBS-mediated retroviral silencing.  
The small hairpin RNA (shRNA) sequences for knockdown indicated 
proteins were listed below. Those sequences were cloned into pLKO.1 vector 
and transduced into F9 cells by VSVG pseudotyped viruses. The levels of 
knockdown were verified by quantitative real time PCR. The restriction fold 
was calculated from viral transduction assay using pseudotyped PBSpro or 
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           Studies of regulation of retroviral replication in stem cells and differentiated cells 
will provide us insights as to how organisms restrict exogenous viral infection to protect 
their genome integrity, and yet also allow moderate retroviral activities to develop 
necessary diversity for adapting to environmental changes. The primary focus of this 
thesis has been to investigate how mouse embryonic cells restrict retroviral infection and 
how the restriction is lost during differentiation. In Chapter 2, we demonstrated that the 
essential restriction factor of MLV ZFP809 is subject to proteasomal degradation in 
differentiated cells, but is relatively stable in stem cells.. In Chapter 3, we characterized 
the role of another stem cell specific protein, L1td1, in retroviral silencing in embryonic 
cells. In this chapter, the results will be reviewed briefly and explored in broader context. 
In addition, future directions will be discussed.   
4.1  Proteasomal regulation of ZFP809, a retroviral repressor 
          ZFP809 was identified as the zinc finger protein binding to the PBS of proviral 
DNA and initiating the retroviral silencing in stem cells (Wolf and Goff, 2009). ZFP809 
protein is not expressed in differentiated cells (Wolf and Goff, 2009), but the levels of 
ZFP809 mRNA are approximately the same in stem cells and differentiated cells. which 
indicates that some post-transcriptional mechanism is involved in the depletion of ZFP809 
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proteins. In Chapter 2, our observations showed that ZFP809 is degraded rapidly in 
differentiated cells but stable in stem cells. The degradation is mediated by the 
proteasomal pathway and very likely ubiquitin-dependent.  The 50 amino acids and the 
lysine residue in the C-terminal of the protein are essential for the turnover of ZFP809. 
Surprisingly, Trim28 protein, which is recruited by ZFP809 and responsible for formation 
of silencing complexes, can promote the degradation of ZFP809 in differentiated cells. 
Using small drug MLN4924 also revealed that neddylation, perhaps by a cullin family 
protein might be involved in the degradation of ZFP809.  
          It has been known for many years that the transcription of MLV DNA is silenced in 
murine stem cells but not in differentiated cells. A zinc finger protein, ZFP809 binds 
directly to the PBS of MLV proviral DNA and initiates the silencing. Ectopic expression 
of ZFP809 alone in murine or human differentiated cells is sufficient to establish the 
silencing. In murine stem and differentiated cells, the mRNA levels of ZFP809 are 
comparable. We discovered that ZFP809 proteins are turned over rapidly in differentiated 
cells but are stable in stem cells, which may explain why the replication of MLV is 
restricted in stem cells but not in differentiated cells. After tethering to the PBS, ZFP809 
recruits Trim28 through KRAB box and then other transcription repressors to block the 
expression of viral genes. Though trim28 is an essential component of the silencing 
complex in stem cells, it promotes the degradation of ZFP809 in differentiated cells. 
Overall the silencing machinery of MLV is subtly regulated. 
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         In general, around 40% of variation in protein concentration can be explained by 
their mRNA abundance (Vogel and Marcotte, 2012). In many other cases, regulatory 
processes, occurring after transcription, such as RNA processing, translational regulation, 
and protein degradation, are controlling the abundances of proteins. In this work, we found 
that the key component of retroviral silencing complex, ZFP809, is regulated by the 
proteasomal protein degradation system. After translation, ZFP809 is subjected to the 
ubiquitin-mediated degradation. Post-translational regulation via ubiquitin proteasome 
system (UPS) plays an important role in retroviral replication. Ubiquitin is involved in the 
traffic and processing of Gag polyprotein, and in the budding of retroviral particles 
(Patnaik et al., 2000; Schubert et al., 2000; Strack et al., 2000). HIV subverts the Cullin-
Ring finger Ubquitin ligases (CRLs) to overcome some restriction factors and optimize its 
replication and spreading (Barry and Fruh, 2006; Malim, 2014). Here we discovered that 
the UPS degrades the key restriction factor blocking the transcription of MLV in 
embryonic stem cells and so allows its replication in differentiated cells. Depletion of 
ZFP809 might also relieve the restriction of those endogenous retroelements using PBSpro.  
          Ubiquitin proteins are transferred to targets through three ligases: E1, E2 and E3. 
The specificity of substrates selection usually depends on the E3 ligases. Ring domain, F-
box and HECT domain containing proteins can serve as E3 ligases(Deshaies and Joazeiro, 
2009). TRIM28, which containing a Ring domain, is a potential E3 ligase(Iyengar and 
Farnham, 2011). Trim28 can promote the degradation of ZFP809 but it cannot be 
concluded that Trim28 serves as an E3 ligase for ZFP809. Usually Ring-finger proteins 
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function with cullin proteins as the Cullin-Ring finger complex to target proteins for 
degradation. The PHD domain of TRIM28 functions as an intramolecular E3 ligase that 
sumoylates the adjacent TRIM28 bromo domain, which recruits SETDB1, a 
transcriptional repressor (Ivanov et al., 2007). Another protein modification, 
phosphorylation is also important for its function in transcription repression (Li et al., 
2007). The phosphorylated and sumoylated Trim28, has a shorter half-life and is targeted 
for degradation by RNF4 (Kuo et al., 2014). It seems that after silencing the specific 
chromatin region, Trim28 and its associated transcription repressors undergo protein 
degradation. The silenced MLV in stem cells cannot be activated during differentiation, 
because the restriction complex has already placed many silencing marks on the proviral 
DNA(Yao et al., 2004). Once the silencing is done, Trim28, ZFP809 and other 
transcription repressors might be subject to degradation. Future studies aimed at 
identifying the E3 ligase of ZFP809 and the mechanism of ZFP809 degradation will give 
us a more detailed view as to how the UPS regulates retroviral replication. 
        ZFP809 not only is required for the initiation of silencing of exogenous retroviruses, 
but also for the silencing of endogenous retroelements using PBSpro sequence (Wolf et al., 
2015). Investigation of how ZFP809 protein is regulated in different cell types will also 
extend our understanding of how endogenous retroviruses are regulated in those cells. 
There are several classes of experiments that would allow us to further delineate the fine-
tuned regulation of ZFP809 and retroviruses it tethers to.  
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          Trim28 is a RING domain containing factor, which has been shown to have E3 
ligase activity (Chen et al., 2011; Ivanov et al., 2007). Abolishing the interaction between 
Trim28 and ZFP809 stabilized ZFP809 in differentiated cells. Taken together with the 
observation that depletion of Trim28 using siRNA also stabilized ZFP809 in those cells, 
this result suggests that Trim28 promotes the degradation of ZFP809. We cannot yet 
conclude that Trim28 is the specific E3 ligase that links ubiquitin proteins to ZFP809 and 
targets the protein to proteasomes for degradation. In vitro ubiquitination assay could be 
employed to demonstrate if Trim28 directly ligates ubiquitin to ZFP809 (Zhao et al., 2012). 
Specificity and modification problems should be considered when doing in vitro 
experiments. Mutated Trim28 without E3 ligase activity could be introduced into Trim28 
depleted cells to test its role in ZFP809 degradation.           
          Ring domain-containing proteins often couple with cullin family proteins to form 
Cullin-RING ligases (CRL) for protein degradation (Deshaies and Joazeiro, 2009). Cullin 
proteins serve as scaffold for recruiting E2, E3 ligases and substrate (Bosu and Kipreos, 
2008). The neddylation, resulting in structural change of cullin proteins, is important for 
the interactions of E2, E3 and substrate on Cullin scaffold (Merlet et al., 2009). The 
neddylation inhibitor MLN4924 stabilized ZFP809 in differentiated cells, indicating 
potential involvement of neddylation, perhaps a cullin protein in ZFP809 degradation. 
There are seven Cullin proteins in mammals (Hua and Vierstra, 2011). Analyzing the 
expression profile of cullin proteins to identify differentiated cell-specific cullins would 
narrow down the targets. Then using siRNAs to knock down cullin proteins and testing the 
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stability of ZFP809 upon cullin depletion will allow us to characterize which cullin protein 
is responsible for ZFP809 degradation. Since MLN4924 inhibits neddylation globally, 
there might be other pathways deactivated by the drug and indirectly affecting the 
degradation of ZFP809.  
         Biochemical purification could also be employed to identify the E3 ligase for 
ZFP809 directly. Affinity purification of E3 ligases bound to immobilized substrates have 
been shown before (Reiss and Hershko, 1990). ZFP809 could be used as a bait to enrich 
the E3 ligases. As we showed above, full-length ZFP809 protein is stable in stem cells and 
a truncated ZFP809 protein, ZFP809(1-353) is not turned over in differentiated cells. 
Bound proteins from stem cells and ZFP809(1-353) could be used as controls. The 
interactions between E3 ligase and substrate are relatively weak and transient. Methods 
such as protein-protein linkers that could stabilize protein interactions should be used 
during the purification.  
         In addition to affinity purification, libraries for screening of E3 ligases are available. 
In order to create a clear phenotype for screening, a construct with mCherry IRES GFP-
tagged ZFP809 could be made. The construct could be introduced into cells expressing the 
siRNA library by either viral transduction or transfection.  High ratio of GFP/mCherry is 
an indication of stabilizing of ZFP809 by the specific siRNAs.  
          As we observed above, Trim28 promotes ZFP809 degradation in differentiated cells, 
however, the interaction between Trim28 and ZFP809 are present in stem cells as well. In 
stem cells, ZFP809 should be stable enough to silence the incoming retroviruses. It would 
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be interesting to reveal what mechanisms regulate the different stability of ZFP809 in 
different type of cells, which might lead to the discovery of the pathways that host cells 
use to regulate exogenous and endogenous viral activities. In order to identify factors 
involving in the signal of ZFP809 degradation, a genome-wide screening (CRISPR or 
shRNA) using the phenotype described in last paragraph could be performed.  There are 
numerous studies on how the transcription of viral DNA is blocked, but there is little 
known about the upstream signal for initiating or removing the silencing. The screen 
would reveal factors involved in the signal pathway leading to degradation.  
          Retroviral replication is blocked in stem cells, but not in differentiated cells. To 
investigate in what stage of differentiation that host cells are starting to lose the restriction 
would give us a picture of when host cells need to protect the genome from exogenous 
infection and mutagenesis by endogenous retroviruses. Viral transduction or transfection 
assays with a reporter gene could be used to measure the restriction fold during the 
differentiation of stem cells. Then using high-throughput technology to profile the 
expression patterns of stem cells and the cells in pluripotent transition would reveal 
important transcriptional differences that might be essential for the regulation of 
exogenous and endogenous retroviruses. 
          Global ChIP-sequencing revealed that ZFP809 controls the replication of 
endogenous retroviruses (Wolf et al., 2015). Further studies of ZFP809 regulation would 
reveal how host cells respond to the exogenous and endogenous retroviral activities.  
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          Most of retroelements inside mammalian genomes are tightly regulated. Most of 
them are controlled by the epigenetic machinery (Rowe and Trono, 2011). During the 
development of mammalian organisms, the methylation pattern of DNA are 
reprogrammed several times and the activities of most of the retroelements are hyperactive 
during the removal of methylation markers, which probably introduce the somatic 
mutations for genome expansion (Messerschmidt et al., 2014). For example, the non-LTR 
retrotransposon, Line-1 is extremely active in neuroprogenitor cells, which expands the 
neuronal diversity and is important for the development of neuron system (Thomas and 
Muotri, 2012).  Depletion of ZFP809 using the ubiquitination system, which allows the 
retrotransposition of endogenous retroviruses using PBSpro, might also result in somatic 
mutations in the genome and contribute to the genetic diversity. But the exact function is 
not known yet. 
4.2 Components of RBS silencing complex 
          L1td1, a stem cell-specific transcript, was identified during the purification of RBS 
silencing complex. Human L1td1 plays a crucial role in maintaining pluripotency of 
human stem cells (Narva et al., 2012), probably through their involvement in RNA 
biology (Emani et al., 2015). However, the mouse L1td1 seems to be dispensable for 
generation or maintenance of pluripotency (Iwabuchi et al., 2011). Our observation 
suggests that depletion of L1td1 in mouse embryonic cells partially relieves the restriction 
from PBS, by interacting with a key component of RBS silencing complex, Trim28.  
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          The evolutionary analysis revealed that L1td1 genes of different species originated 
from a common ancestor and had genome defense activity. It lost or changed the function 
during evolution (McLaughlin et al., 2014). The role of L1td1 in retroviral silencing in 
mouse embryonic cells suggests that L1td1 may retain its function in mouse. L1td1 was 
also identified as a protein interacting with Dnmt3L, an important DNA methytransferase. 
The status of DNA methylation is positively associated with the expression of retroviral 
genes (Matsui et al., 2010). However, DNA methylation was proposed to maintain the 
long-term silencing of retroviral DNA but not initiation of the silencing (Cherry et al., 
2000; Lorincz et al., 2000; Lorincz et al., 2002; Yao et al., 2004). The interaction between 
Dnmt3L and L1td1 might explain the minor effect of L1td1 in retroviral silencing, because 
depletion of de novo DNA methytransferase only increased the retroviral activity 
moderately (Laker et al., 1998; Niwa et al., 1983). To study the relevance of L1td1 and 
DNA methylation, protein-protein interaction assays should be done to confirm the 
interaction between Dnmt3L and L1td1. DNA methylation status of proviral DNA in 
L1td1 depleted cells could be monitored by bisulfate sequencing. There will be less DNA 
methylation in L1td1 depleted cells if L1td1 truly participates in the recruitment of DNA 
methylation machinery to proviral DNA.   
        L1td1 plays an important role in the stem cell biology in humans, probably in post-
trasncriptional regulation or RNA biology (Emani et al., 2015). It has been demonstrated 
that retroelement activities are associated with the pluripotency of stem cells (Coufal et al., 
2009; Macfarlan et al., 2012). It will be interesting to learn if L1td1 is involved in the 
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regulation of retroelements in human stem cells. L1td1 might not participate in the 
silencing of exogenous HIV and MLV since they are not likely to be silenced in human 
embryonic cells (Macia et al., 2011). As revealed by evolutionary analysis, L1td1 might 
have originated as defense against LINE-1 elements (McLaughlin et al., 2014). The 
activity of engineered Line-1 or expression level of Line-1 RNA in L1td1 depleted cell 
could be tested to investigate L1td1’s role in Line-1 retrotransposition. Global profiling of 
the expression pattern of L1td1 depleted cells would reveal more retro-transposition 
activity change.  
        In addition to ZFP809, Trim28, HP1, EBP1 and L1td1, there are likely to be other 
factors in the silencing complex. Further identification of components in the silencing 
complex would allow us to understand the establishment of retroviral silencing 
comprehensively. The failure to detect restriction fold change in cell lines with depleting 
single proteins of NuRD complex might be the result of redundancy. Knockdown or 
knockout all of the homologous proteins should be achieved to test their effects on 
retroviral silencing. A global screening of factors that relieves the retroviral silencing 
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